BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375-1383. [PMID: 21995385 DOI: 10.1056/nejmoa1103042] [Cited by in Crossref: 875] [Cited by in F6Publishing: 387] [Article Influence: 79.5] [Reference Citation Analysis]
Number Citing Articles
1 Derouet MF, Dakpo E, Wu L, Zehong G, Conner J, Keshavjee S, de Perrot M, Waddell T, Elimova E, Yeung J, Darling GE. miR-145 expression enhances integrin expression in SK-GT-4 cell line by down-regulating c-Myc expression. Oncotarget 2018;9:15198-207. [PMID: 29632636 DOI: 10.18632/oncotarget.24613] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 de Vegt F, Gommers JJJ, Groenewoud H, Siersema PD, Verbeek ALM, Peters Y, Broeders MJM. Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041. Int J Cancer 2022;150:420-30. [PMID: 34605022 DOI: 10.1002/ijc.33836] [Reference Citation Analysis]
3 Gregson EM, Fitzgerald RC. Biomarkers for dysplastic Barrett's: ready for prime time? World J Surg 2015;39:568-77. [PMID: 24844657 DOI: 10.1007/s00268-014-2640-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
4 Kaul V, Bittner K, Ullah A, Kothari S. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center. Dis Esophagus 2020;33:doz095. [PMID: 31909783 DOI: 10.1093/dote/doz095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yates M, Cheong E, Luben R, Igali L, Fitzgerald R, Khaw KT, Hart A. Body mass index, smoking, and alcohol and risks of Barrett’s esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Dig Dis Sci. 2014;59:1552-1559. [PMID: 24500448 DOI: 10.1007/s10620-013-3024-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
6 Schoppmann SF, Azari R, Riegler FM. Selected commentary to "Incidence of adenocarcinoma among patients with Barrett's esophagus". Eur Surg 2012;44:291-5. [DOI: 10.1007/s10353-012-0101-z] [Reference Citation Analysis]
7 Kostadinov RL, Kuhner MK, Li X, Sanchez CA, Galipeau PC, Paulson TG, Sather CL, Srivastava A, Odze RD, Blount PL, Vaughan TL, Reid BJ, Maley CC. NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet 2013;9:e1003553. [PMID: 23785299 DOI: 10.1371/journal.pgen.1003553] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
8 Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 2014;94:329-354. [PMID: 24692350 DOI: 10.1152/physrev.00040.2012] [Cited by in Crossref: 831] [Cited by in F6Publishing: 713] [Article Influence: 103.9] [Reference Citation Analysis]
9 Choi KKH, Sanagapalli S. Barrett’s esophagus: Review of natural history and comparative efficacy of endoscopic and surgical therapies. World J Gastrointest Oncol 2022; 14(3): 568-586 [PMID: 35321279 DOI: 10.4251/wjgo.v14.i3.568] [Reference Citation Analysis]
10 Zhang Z, Curran G, Altinok Dindar D, Wu Y, Wu H, Sharpton T, Zhao L, Lieberman D, Otaki F. Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review. Clin Transl Gastroenterol 2021;12:e00390. [PMID: 34446641 DOI: 10.14309/ctg.0000000000000390] [Reference Citation Analysis]
11 Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK. Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila). 2014;7:114-127. [PMID: 24253313 DOI: 10.1158/1940-6207.CAPR-13-0289] [Cited by in Crossref: 107] [Cited by in F6Publishing: 65] [Article Influence: 11.9] [Reference Citation Analysis]
12 Labenz J. [Barrett's esophagus]. Internist (Berl) 2016;57:1079-92. [PMID: 27757487 DOI: 10.1007/s00108-016-0152-5] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
13 Verbeek RE, Siersema PD, Ten Kate FJ, Fluiter K, Souza RF, Vleggaar FP, Bus P, van Baal JW. Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression. J Gastroenterol 2014;49:1121-34. [PMID: 23955118 DOI: 10.1007/s00535-013-0862-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
14 Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149:302-17.e1. [PMID: 25957861 DOI: 10.1053/j.gastro.2015.04.053] [Cited by in Crossref: 182] [Cited by in F6Publishing: 175] [Article Influence: 26.0] [Reference Citation Analysis]
15 Davern M, Donlon NE, Power R, Hayes C, King R, Dunne MR, Reynolds JV. The tumour immune microenvironment in oesophageal cancer. Br J Cancer 2021;125:479-94. [PMID: 33903730 DOI: 10.1038/s41416-021-01331-y] [Reference Citation Analysis]
16 Theron BT, Padmanabhan H, Aladin H, Smith P, Campbell E, Nightingale P, Cooper BT, Trudgill NJ. The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort. United European Gastroenterol J 2016;4:754-61. [PMID: 28408992 DOI: 10.1177/2050640616632419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
18 Masclee GM, Coloma PM, Spaander MC, Kuipers EJ, Sturkenboom MC. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study. BMJ Open 2015;5:e006640. [PMID: 25633286 DOI: 10.1136/bmjopen-2014-006640] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
19 Lipman G, Haidry RJ. Endoscopic management of Barrett's and early oesophageal neoplasia. Frontline Gastroenterol 2017;8:138-42. [PMID: 28839898 DOI: 10.1136/flgastro-2016-100763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Graham D, Lipman G, Sehgal V, Lovat LB. Monitoring the premalignant potential of Barrett's oesophagus'. Frontline Gastroenterol 2016;7:316-22. [PMID: 27761232 DOI: 10.1136/flgastro-2016-100712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 Lin EC, Holub J, Lieberman D, Hur C. Low Prevalence of Suspected Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease Without Alarm Symptoms. Clin Gastroenterol Hepatol 2019;17:857-63. [PMID: 30196157 DOI: 10.1016/j.cgh.2018.08.066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Liu W, Yang LJ, Liu YL, Yuan DS, Zhao ZM, Wang Q, Yan Y, Pan HF. Dynamic characterization of intestinal metaplasia in the gastric corpus mucosa of Atp4a-deficient mice. Biosci Rep 2020;40:BSR20181881. [PMID: 31904088 DOI: 10.1042/BSR20181881] [Reference Citation Analysis]
23 Bertani H, Frazzoni M, Dabizzi E, Pigò F, Losi L, Manno M, Manta R, Bassotti G, Conigliaro R. Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett’s esophagus surveillance program. Dig Dis Sci. 2013;58:188-193. [PMID: 22875309 DOI: 10.1007/s10620-012-2332-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
24 Hur C, Choi SE, Rubenstein JH, Kong CY, Nishioka NS, Provenzale DT, Inadomi JM. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology. 2012;143:567-575. [PMID: 22626608 DOI: 10.1053/j.gastro.2012.05.010] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 11.2] [Reference Citation Analysis]
25 Aranda-Hernandez J, Cirocco M, Marcon N. Treatment of dysplasia in barrett esophagus. Clin Endosc 2014;47:55-64. [PMID: 24570884 DOI: 10.5946/ce.2014.47.1.55] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Yusuf A, Fitzgerald RC. Screening for Barrett's Oesophagus: Are We Ready for it? Curr Treat Options Gastroenterol 2021;:1-16. [PMID: 33746508 DOI: 10.1007/s11938-021-00342-1] [Reference Citation Analysis]
27 van Nistelrooij AM, van Marion R, Koppert LB, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Wijnhoven BP, Dinjens WN. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples. BMC Res Notes 2017;10:144. [PMID: 28376920 DOI: 10.1186/s13104-017-2456-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
28 Kirwan A, Utratna M, O'Dwyer ME, Joshi L, Kilcoyne M. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics. Biomed Res Int 2015;2015:490531. [PMID: 26509158 DOI: 10.1155/2015/490531] [Cited by in Crossref: 93] [Cited by in F6Publishing: 81] [Article Influence: 13.3] [Reference Citation Analysis]
29 Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RGP, Iyer PG, Anderson LA, Bernstein L, Chow WH, Hardie LJ, Lagergren J, Liu G, Risch HA, Wu AH, Ye W, Bird NC, Shaheen NJ, Gammon MD, Corley DA, Caldas C, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J; Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)., Esophageal Adenocarcinoma GenEtics Consortium (EAGLE)., Wellcome Trust Case Control Consortium 2 (WTCCC2). Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol 2016;17:1363-73. [PMID: 27527254 DOI: 10.1016/S1470-2045(16)30240-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 51] [Article Influence: 13.8] [Reference Citation Analysis]
30 Romano-Keeler J, Zhang J, Sun J. The Life-Long Role of Nutrition on the Gut Microbiome and Gastrointestinal Disease. Gastroenterol Clin North Am 2021;50:77-100. [PMID: 33518170 DOI: 10.1016/j.gtc.2020.10.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yang L, Francois F, Pei Z. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin Cancer Res. 2012;18:2138-2144. [PMID: 22344232 DOI: 10.1158/1078-0432.ccr-11-0934] [Cited by in Crossref: 93] [Cited by in F6Publishing: 63] [Article Influence: 9.3] [Reference Citation Analysis]
32 Sharma P, Gautam SD, Rajendra S. Importance of investigating high-risk human papillomavirus in lymph node metastasis of esophageal adenocarcinoma. World J Gastroenterol 2020; 26(21): 2729-2739 [PMID: 32550750 DOI: 10.3748/wjg.v26.i21.2729] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Chadwick G, Varagunam M, Brand C, Riley SA, Maynard N, Crosby T, Michalowski J, Cromwell DA. Coding of Barrett's oesophagus with high-grade dysplasia in national administrative databases: a population-based cohort study. BMJ Open 2017;7:e014281. [PMID: 28600361 DOI: 10.1136/bmjopen-2016-014281] [Reference Citation Analysis]
34 Li D, Bautista MC, Jiang SF, Daryani P, Brackett M, Armstrong MA, Hung YY, Postlethwaite D, Ladabaum U. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol. 2016;111:1104-1113. [PMID: 27185078 DOI: 10.1038/ajg.2016.188] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
35 Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012;143:336-346. [PMID: 22537613 DOI: 10.1053/j.gastro.2012.04.032] [Cited by in Crossref: 263] [Cited by in F6Publishing: 225] [Article Influence: 26.3] [Reference Citation Analysis]
36 Yang D, Draganov PV. Expanding Role of Third Space Endoscopy in the Management of Esophageal Diseases. Curr Treat Options Gastroenterol 2018;16:41-57. [PMID: 29435819 DOI: 10.1007/s11938-018-0169-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
37 Feuerstein JD, Castillo NE, Akbari M, Belkin E, Lewandowski JJ, Hurley CM, Lloyd S, Leffler DA, Cheifetz AS. Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus. Dig Dis Sci 2016;61:2812-22. [PMID: 27307064 DOI: 10.1007/s10620-016-4222-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
38 Suresh Kumar VC, Harne P, Patthipati VS, Subedi A, Masood U, Sharma A, Goyal F, Aggarwal N, Sapkota B. Wide-area transepithelial sampling in adjunct to forceps biopsy increases the absolute detection rates of Barrett's oesophagus and oesophageal dysplasia: a meta-analysis and systematic review. BMJ Open Gastroenterol 2020;7:e000494. [PMID: 32928869 DOI: 10.1136/bmjgast-2020-000494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Kroep S, Lansdorp-Vogelaar I, van der Steen A, Inadomi JM, van Ballegooijen M. The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions. Med Decis Making 2015;35:726-33. [PMID: 25277672 DOI: 10.1177/0272989X14551640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Cardoso J, Mesquita M, Dias Pereira A, Bettencourt-Dias M, Chaves P, Pereira-Leal JB. CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression. PLoS One 2016;11:e0161967. [PMID: 27583562 DOI: 10.1371/journal.pone.0161967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
41 Srivastava A, Golden KL, Sanchez CA, Liu K, Fong PY, Li X, Cowan DS, Rabinovitch PS, Reid BJ, Blount PL, Odze RD. High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus. PLoS One 2015;10:e0133403. [PMID: 26230607 DOI: 10.1371/journal.pone.0133403] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
42 Chadwick G, Faulkner J, Ley-Greaves R, Vlavianos P, Goldin R, Hoare J. Treatment of dysplastic Barrett’s Oesophagus in lower volume centres after structured training. World J Gastrointest Endosc 2015; 7(1): 66-72 [PMID: 25610536 DOI: 10.4253/wjge.v7.i1.66] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Reid BJ. Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective. Cell Mol Gastroenterol Hepatol 2017;3:359-66. [PMID: 28462378 DOI: 10.1016/j.jcmgh.2017.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Raphael KL, Stewart M, Sejpal DV, Cheung M, Whitson MJ, Han D, Benias PC, Lee C, Miller LS, Trindade AJ. Adjunctive Yield of Wide-Area Transepithelial Sampling for Dysplasia Detection After Advanced Imaging and Random Biopsies in Barrett's Esophagus. Clin Transl Gastroenterol 2019;10:e00107. [PMID: 31833863 DOI: 10.14309/ctg.0000000000000107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
45 Belghazi K, Cipollone I, Bergman JJ, Pouw RE. Current Controversies in Radiofrequency Ablation Therapy for Barrett's Esophagus. Curr Treat Options Gastroenterol 2016;14:1-18. [PMID: 26891725 DOI: 10.1007/s11938-016-0080-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Kubo A, Cook MB, Shaheen NJ, Vaughan TL, Whiteman DC, Murray L, Corley DA. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut. 2013;62:1684-1691. [PMID: 23355549 DOI: 10.1136/gutjnl-2012-303753] [Cited by in Crossref: 95] [Cited by in F6Publishing: 83] [Article Influence: 10.6] [Reference Citation Analysis]
47 Jin Z, Wang L, Zhang Y, Cheng Y, Gao Y, Feng X, Dong M, Cao Z, Chen S, Yu H, Zhao Z, Zhang X, Liu J, Mori Y, Fan X, Meltzer SJ. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma. Sci Rep 2013;3:2838. [PMID: 24088706 DOI: 10.1038/srep02838] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
48 di Pietro M, Alzoubaidi D, Fitzgerald RC. Barrett's esophagus and cancer risk: how research advances can impact clinical practice. Gut Liver 2014;8:356-70. [PMID: 25071900 DOI: 10.5009/gnl.2014.8.4.356] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
49 Qumseya B, Bukannan A, Rosasco R, Liu X, Qumseya A. Surveillance of Barrett’s esophagus using wide-area transepithelial sampling: systematic review and meta-analysis. Endosc Int Open 2022;10:E394-402. [DOI: 10.1055/a-1783-9015] [Reference Citation Analysis]
50 Wani S, Gaddam S. Editorial: Best Practices in Surveillance of Barrett's Esophagus. Am J Gastroenterol 2017;112:1056-60. [PMID: 28725066 DOI: 10.1038/ajg.2017.117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
51 Ertan A, Zaheer I, Correa AM, Thosani N, Blackmon SH. Photodynamic therapy vs radiofrequency ablation for Barrett’s dysplasia: Efficacy, safety and cost-comparison. World J Gastroenterol 2013; 19(41): 7106-7113 [PMID: 24222954 DOI: 10.3748/wjg.v19.i41.7106] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
52 Lin R, Li C, Liu Z, Wu R, Lu J. Genome-wide DNA methylation profiling identifies epigenetic signatures of gastric cardiac intestinal metaplasia. J Transl Med 2020;18:292. [PMID: 32736574 DOI: 10.1186/s12967-020-02453-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Perry KA, Walker JP, Salazar M, Suzo A, Hazey JW, Melvin WS. Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center. Surg Endosc. 2014;28:777-782. [PMID: 24122245 DOI: 10.1007/s00464-013-3240-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
54 Orman ES, Kim HP, Bulsiewicz WJ, Cotton CC, Dellon ES, Spacek MB, Chen X, Madanick RD, Pasricha S, Shaheen NJ. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett’s esophagus with radiofrequency ablation. Am J Gastroenterol. 2013;108:187-195; quiz 196. [PMID: 23247578 DOI: 10.1038/ajg.2012.413] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
55 Alkhayyat M, Kumar P, Sanaka KO, Thota PN. Chemoprevention in Barrett's esophagus and esophageal adenocarcinoma. Therap Adv Gastroenterol 2021;14:17562848211033730. [PMID: 34434254 DOI: 10.1177/17562848211033730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Huhta H, Helminen O, Kauppila JH, Takala H, Metsikkö K, Lehenkari P, Saarnio J, Karttunen T. Toll-like receptor 9 expression in the natural history of Barrett mucosa. Virchows Arch 2015;467:9-18. [PMID: 25838081 DOI: 10.1007/s00428-015-1770-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
57 Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016;111:30-50; quiz 51. [PMID: 26526079 DOI: 10.1038/ajg.2015.322] [Cited by in Crossref: 793] [Cited by in F6Publishing: 630] [Article Influence: 113.3] [Reference Citation Analysis]
58 Yachimski P, Hur C. Evidence-based endoscopic management of Barrett's esophagus. Gastroenterol Rep (Oxf) 2015;3:54-62. [PMID: 25237038 DOI: 10.1093/gastro/gou059] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
59 Halland M, Katzka D, Iyer PG. Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus. World J Gastroenterol 2015; 21(21): 6479-6490 [PMID: 26074687 DOI: 10.3748/wjg.v21.i21.6479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
60 Gatenby P, Caygill C, Wall C, Bhatacharjee S, Ramus J, Watson A, Winslet M. Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus. World J Gastroenterol 2014; 20(28): 9611-9617 [PMID: 25071359 DOI: 10.3748/wjg.v20.i28.9611] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
61 Lisovsky M, Srivastava A. Barrett Esophagus: Evolving Concepts in Diagnosis and Neoplastic Progression. Surg Pathol Clin 2013;6:475-96. [PMID: 26839097 DOI: 10.1016/j.path.2013.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Bandla S, Peters JH, Ruff D, Chen SM, Li CY, Song K, Thoms K, Litle VR, Watson T, Chapurin N, Lada M, Pennathur A, Luketich JD, Peterson D, Dulak A, Lin L, Bass A, Beer DG, Godfrey TE, Zhou Z. Comparison of cancer-associated genetic abnormalities in columnar-lined esophagus tissues with and without goblet cells. Ann Surg. 2014;260:72-80. [PMID: 24509200 DOI: 10.1097/sla.0000000000000424] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
63 Werbrouck E, De Hertogh G, Sagaert X, Coremans G, Willekens H, Demedts I, Bisschops R. Oesophageal biopsies are insufficient to predict final histology after endoscopic resection in early Barrett's neoplasia. United European Gastroenterol J 2016;4:663-8. [PMID: 27733908 DOI: 10.1177/2050640615626320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Beales ILP, Hensley A, Loke Y. Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition. World J Gastrointest Pharmacol Ther 2013; 4(3): 69-79 [PMID: 23919219 DOI: 10.4292/wjgpt.v4.i3.69] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
65 Zaninotto G, Bennett C. Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? World J Surg 2015;39:578-85. [PMID: 24919861 DOI: 10.1007/s00268-014-2661-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
66 Omidvari AH, Ali A, Hazelton WD, Kroep S, Lee M, Naber SK, Lauren BN, Ostvar S, Richmond E, Kong CY, Rubenstein JH, Lansdorp-Vogelaar I, Luebeck G, Hur C, Inadomi J. Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling. Clin Gastroenterol Hepatol 2020;18:1961-9. [PMID: 31816445 DOI: 10.1016/j.cgh.2019.11.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
67 DeMeester SR. Barrett's oesophagus: treatment with surgery. Best Pract Res Clin Gastroenterol 2015;29:211-7. [PMID: 25743467 DOI: 10.1016/j.bpg.2014.12.004] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
68 Pich O, Bailey C, Watkins TBK, Zaccaria S, Jamal-Hanjani M, Swanton C. The translational challenges of precision oncology. Cancer Cell 2022:S1535-6108(22)00164-7. [PMID: 35487215 DOI: 10.1016/j.ccell.2022.04.002] [Reference Citation Analysis]
69 Walavalkar V, Patwardhan RV, Owens CL, Lithgow M, Wang X, Akalin A, Nompleggi DJ, Zivny J, Wassef W, Marshall C, Levey J, Walter O, Fischer AH. Utility of liquid-based cytologic examination of distal esophageal brushings in the management of Barrett esophagus: a prospective study of 45 cases. J Am Soc Cytopathol 2015;4:113-21. [PMID: 31051691 DOI: 10.1016/j.jasc.2014.09.208] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
70 Chen M, Ye A, Wei J, Wang R, Poon K. Deoxycholic Acid Upregulates the Reprogramming Factors KFL4 and OCT4 Through the IL-6/STAT3 Pathway in Esophageal Adenocarcinoma Cells. Technol Cancer Res Treat 2020;19:1533033820945302. [PMID: 32869704 DOI: 10.1177/1533033820945302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Chung CS, Wang HP. Screening for precancerous lesions of upper gastrointestinal tract: from the endoscopists' viewpoint. Gastroenterol Res Pract 2013;2013:681439. [PMID: 23573079 DOI: 10.1155/2013/681439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
72 Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245-1255. [PMID: 23644385 DOI: 10.1016/j.cgh.2013.03.039] [Cited by in Crossref: 180] [Cited by in F6Publishing: 135] [Article Influence: 20.0] [Reference Citation Analysis]
73 Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 2018;95:81-90. [PMID: 29843157 DOI: 10.1159/000488489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Brown J, Alsop B, Gupta N, Buckles DC, Olyaee MS, Vennalaganti P, Kanakadandi VN, Saligram S, Sharma P. Effectiveness of focal vs. balloon radiofrequency ablation devices in the treatment of Barrett's esophagus. United European Gastroenterol J 2016;4:236-41. [PMID: 27087952 DOI: 10.1177/2050640615594549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Hamade N, Sharma P. Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times. Curr Gastroenterol Rep 2017;19:48. [PMID: 28819902 DOI: 10.1007/s11894-017-0589-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
76 Clemons NJ, Phillips WA, Lord RV. Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction. Cancer Biol Ther. 2013;14:782-795. [PMID: 23792587 DOI: 10.4161/cbt.25362] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
77 Alashkar B, Faulx AL, Hepner A, Pulice R, Vemana S, Greer KB, Isenberg GA, Falck-Ytter Y, Chak A. Development of a program to train physician extenders to perform transnasal esophagoscopy and screen for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2014;12:785-792. [PMID: 24161352 DOI: 10.1016/j.cgh.2013.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
78 Smith E, Ruszkiewicz AR, Jamieson GG, Drew PA. IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation. Br J Cancer 2014;110:775-82. [PMID: 24357797 DOI: 10.1038/bjc.2013.783] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
79 Chipidza FE, Wallwork RS, Stern TA. Impact of the Doctor-Patient Relationship. Prim Care Companion CNS Disord 2015;17. [PMID: 26835164 DOI: 10.4088/PCC.15f01840] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
80 Yuan S, Norgard RJ, Stanger BZ. Cellular Plasticity in Cancer. Cancer Discov 2019;9:837-51. [PMID: 30992279 DOI: 10.1158/2159-8290.CD-19-0015] [Cited by in Crossref: 104] [Cited by in F6Publishing: 57] [Article Influence: 34.7] [Reference Citation Analysis]
81 Schweigert M, Dubecz A, Stein HJ. Oesophageal cancer--an overview. Nat Rev Gastroenterol Hepatol. 2013;10:230-244. [PMID: 23296250 DOI: 10.1038/nrgastro.2012.236] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
82 Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer. 2017;17:594-604. [PMID: 28860646 DOI: 10.1038/nrc.2017.68] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 18.2] [Reference Citation Analysis]
83 Peery AF, Hoppo T, Garman KS, Dellon ES, Daugherty N, Bream S, Sanz AF, Davison J, Spacek M, Connors D. Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc. 2012;75:945-953.e2. [PMID: 22425272 DOI: 10.1016/j.gie.2012.01.021] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
84 Sun Y, Ma S, Fang L, Wang J, Dong L. Circular stripes were more common in Barrett's esophagus after acetic acid staining. BMC Gastroenterol 2018;18:17. [PMID: 29370762 DOI: 10.1186/s12876-018-0745-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 O'Farrell NJ, Feighery R, Picardo SL, Lynam-Lennon N, Biniecka M, McGarrigle SA, Phelan JJ, MacCarthy F, O'Toole D, Fox EJ, Ravi N, Reynolds JV, O'Sullivan J. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence. BMC Cancer 2016;16:497. [PMID: 27431913 DOI: 10.1186/s12885-016-2544-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
86 Yu M, O'Leary RM, Kaz AM, Morris SM, Carter KT, Chak A, Chandar A, Willis JE, Moinova HR, Markowitz SD, Brenner DE, Anandabapasathy S, Westerhoff M, Wong CJ, Shaheen NJ, Chen Y, Barnholtz-Sloan JS, Grady WM. Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev 2015;24:1890-7. [PMID: 26545406 DOI: 10.1158/1055-9965.EPI-15-0370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
87 Jagadesham VP, Kelty CJ. Low grade dysplasia in Barrett’s esophagus: Should we worry? World J Gastrointest Pathophysiol 2014; 5(2): 91-99 [PMID: 24891980 DOI: 10.4291/wjgp.v5.i2.91] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
88 Chandra S, Gorospe EC, Leggett CL, Wang KK. Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance. Curr Gastroenterol Rep 2013;15:322. [PMID: 23605564 DOI: 10.1007/s11894-013-0322-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
89 Alvi MA, Liu X, O’Donovan M, Newton R, Wernisch L, Shannon NB, Shariff K, di Pietro M, Bergman JJ, Ragunath K. DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett’s esophagus. Clin Cancer Res. 2013;19:878-888. [PMID: 23243219 DOI: 10.1158/1078-0432.ccr-12-2880] [Cited by in Crossref: 54] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
90 Tan MC, Mansour N, White DL, Sisson A, El-Serag HB, Thrift AP. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients. Aliment Pharmacol Ther 2020;52:20-36. [PMID: 32452599 DOI: 10.1111/apt.15760] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
91 Sharaiha RZ, Freedberg DE, Abrams JA, Wang YC. Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett’s esophagus. Dig Dis Sci. 2014;59:1222-1230. [PMID: 24795040 DOI: 10.1007/s10620-014-3186-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
92 Balmadrid B, Hwang JH. Endoscopic resection of gastric and esophageal cancer. Gastroenterol Rep (Oxf) 2015;3:330-8. [PMID: 26510452 DOI: 10.1093/gastro/gov050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
93 Pilonis ND, Killcoyne S, Tan WK, O'donovan M, Malhotra S, Tripathi M, Miremadi A, Debiram-beecham I, Evans T, Phillips R, Morris DL, Vickery C, Harrison J, di Pietro M, Ortiz-fernandez-sordo J, Haidry R, Kerridge A, Sasieni PD, Fitzgerald RC. Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot. The Lancet Oncology 2022. [DOI: 10.1016/s1470-2045(21)00667-7] [Reference Citation Analysis]
94 Kristo I, Schoppmann S. Diagnosis and treatment of benign inflammatory esophageal diseases. Eur Surg 2015;47:188-98. [DOI: 10.1007/s10353-015-0329-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
95 Rosenfeld A, Graham DG, Jevons S, Ariza J, Hagan D, Wilson A, Lovat SJ, Sami SS, Ahmad OF, Novelli M, Rodriguez Justo M, Winstanley A, Heifetz EM, Ben-Zecharia M, Noiman U, Fitzgerald RC, Sasieni P, Lovat LB; BEST2 study group. Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach. Lancet Digit Health 2020;2:E37-48. [PMID: 32133440 DOI: 10.1016/S2589-7500(19)30216-X] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Yamamoto Y, Wang X, Bertrand D, Kern F, Zhang T, Duleba M, Srivastava S, Khor CC, Hu Y, Wilson LH, Blaszyk H, Rolshud D, Teh M, Liu J, Howitt BE, Vincent M, Crum CP, Nagarajan N, Ho KY, McKeon F, Xian W. Mutational spectrum of Barrett's stem cells suggests paths to initiation of a precancerous lesion. Nat Commun 2016;7:10380. [PMID: 26783136 DOI: 10.1038/ncomms10380] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
97 Jiang Y, Gong Y, Rubenstein JH, Wang TD, Seibel EJ. Toward real-time quantification of fluorescence molecular probes using target/background ratio for guiding biopsy and endoscopic therapy of esophageal neoplasia. J Med Imaging (Bellingham) 2017;4:024502. [PMID: 28560244 DOI: 10.1117/1.JMI.4.2.024502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
98 Lutz L, Werner M. [Barrett's esophagus and carcinoma: Recommendations of the S2k guideline 2014 and the S3 guideline 2015]. Pathologe 2016;37:193-8; quiz 199-200. [PMID: 26979429 DOI: 10.1007/s00292-016-0150-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
99 Ek WE, Levine DM, D’Amato M, Pedersen NL, Magnusson PK, Bresso F, Onstad LE, Schmidt PT, Törnblom H, Nordenstedt H. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett’s esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013;105:1711-1718. [PMID: 24168968 DOI: 10.1093/jnci/djt303] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
100 Falk GW. Barrett's oesophagus: frequency and prediction of dysplasia and cancer. Best Pract Res Clin Gastroenterol 2015;29:125-38. [PMID: 25743461 DOI: 10.1016/j.bpg.2015.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
101 Macías-García F, Domínguez-Muñoz JE. Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther 2016; 7(2): 227-234 [PMID: 27158538 DOI: 10.4292/wjgpt.v7.i2.227] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Lee HC, Ahsen OO, Liang K, Wang Z, Figueiredo M, Giacomelli MG, Potsaid B, Huang Q, Mashimo H, Fujimoto JG. Endoscopic optical coherence tomography angiography microvascular features associated with dysplasia in Barrett's esophagus (with video).Gastrointest Endosc. 2017;86:476-484.e3. [PMID: 28167119 DOI: 10.1016/j.gie.2017.01.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
103 Timmer MR, Sun G, Gorospe EC, Leggett CL, Lutzke L, Krishnadath KK, Wang KK. Predictive biomarkers for Barrett's esophagus: so near and yet so far. Dis Esophagus 2013;26:574-81. [PMID: 23316980 DOI: 10.1111/dote.12015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
104 Carr JS, Zafar SF, Saba N, Khuri FR, El-Rayes BF. Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. J Gastrointest Cancer. 2013;44:143-151. [PMID: 23435833 DOI: 10.1007/s12029-013-9480-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
105 Ratcliffe E, Britton J, Hamdy S, McLaughlin J, Ang Y. Developing patient-orientated Barrett's oesophagus services: the role of dedicated services. BMJ Open Gastroenterol 2022;9:e000829. [PMID: 35193888 DOI: 10.1136/bmjgast-2021-000829] [Reference Citation Analysis]
106 Wang Z, Kambhampati S, Cheng Y, Ma K, Simsek C, Tieu AH, Abraham JM, Liu X, Prasath V, Duncan M, Stark A, Trick A, Tsai HL, Wang H, He Y, Khashab MA, Ngamruengphong S, Shin EJ, Wang TH, Meltzer SJ. Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study. Clin Cancer Res 2019;25:2127-35. [PMID: 30670490 DOI: 10.1158/1078-0432.CCR-18-3696] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
107 Arcidiacono D, Dedja A, Giacometti C, Fassan M, Nucci D, Francia S, Fabris F, Zaramella A, Gallagher EJ, Cassaro M, Rugge M, LeRoith D, Alberti A, Realdon S. Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model. Int J Mol Sci 2018;19:E1198. [PMID: 29662006 DOI: 10.3390/ijms19041198] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
108 Kwon KA, Choi IJ, Kim EY, Dong SH, Hahm KB. Highlights of international digestive endoscopy network 2013. Clin Endosc 2013;46:425-35. [PMID: 24143297 DOI: 10.5946/ce.2013.46.5.425] [Reference Citation Analysis]
109 Li J, Xu J, Zheng Y, Gao Y, He S, Li H, Zou K, Li N, Tian J, Chen W, He J. Esophageal cancer: Epidemiology, risk factors and screening. Chin J Cancer Res 2021;33:535-47. [PMID: 34815628 DOI: 10.21147/j.issn.1000-9604.2021.05.01] [Reference Citation Analysis]
110 Gregson EM, Bornschein J, Fitzgerald RC. Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma. Br J Cancer 2016;115:403-10. [PMID: 27441494 DOI: 10.1038/bjc.2016.219] [Cited by in F6Publishing: 32] [Reference Citation Analysis]
111 Steele D, Baig KKK, Peter S. Evolving screening and surveillance techniques for Barrett's esophagus. World J Gastroenterol 2019; 25(17): 2045-2057 [PMID: 31114132 DOI: 10.3748/wjg.v25.i17.2045] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
112 Kauppila JH, Selander KS. Toll-like receptors in esophageal cancer. Front Immunol 2014;5:200. [PMID: 24847326 DOI: 10.3389/fimmu.2014.00200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
113 Hippisley-Cox J, Coupland C. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study. BMJ Open 2015;5:e007825. [PMID: 25783428 DOI: 10.1136/bmjopen-2015-007825] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
114 Yang D, Draganov PV. Endoscopic submucosal dissection compared to endoscopic mucosal resection for early Barrett esophagus neoplasia. Techniques in Gastrointestinal Endoscopy 2018;20:82-90. [DOI: 10.1016/j.tgie.2018.02.001] [Reference Citation Analysis]
115 Tapias LF, Muniappan A, Wright CD, Gaissert HA, Wain JC, Morse CR, Donahue DM, Mathisen DJ, Lanuti M. Short and long-term outcomes after esophagectomy for cancer in elderly patients. Ann Thorac Surg 2013;95:1741-8. [PMID: 23500043 DOI: 10.1016/j.athoracsur.2013.01.084] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
116 Werner M, Laßmann S. [Update on Barrett esophagus and Barrett carcinoma]. Pathologe. 2012;33 Suppl 2:253-257. [PMID: 23011020 DOI: 10.1007/s00292-012-1662-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
117 Chang J, Fasanella K, Chennat J, Davison J, Mcgrath K. Prevalence of esophageal neoplasia in short-segment versus long-segment Barrett’s esophagus. Esophagus 2016;13:151-5. [DOI: 10.1007/s10388-015-0507-3] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
118 Naranjo JD, Saldin LT, Sobieski E, Quijano LM, Hill RC, Chan PG, Torres C, Dziki JL, Cramer MC, Lee YC, Das R, Bajwa AK, Nossair R, Klimak M, Marchal L, Patel S, Velankar SS, Hansen KC, McGrath K, Badylak SF. Esophageal extracellular matrix hydrogel mitigates metaplastic change in a dog model of Barrett's esophagus. Sci Adv 2020;6:eaba4526. [PMID: 32656339 DOI: 10.1126/sciadv.aba4526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
119 Jovov B, Shaheen NJ, Orlando GS, Djukic Z, Orlando RC. Defective barrier function in neosquamous epithelium. The American journal of gastroenterology. 2013;108:386-391. [PMID: 23318477 DOI: 10.1038/ajg.2012.440] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
120 Lin K, Shah J, Ofori E, Shahnazarian V, Reddy M. Dilated Thoracic Esophagus Presenting with Painful Progressive Persistent Dysphagia and Leukocytosis of Unknown Origin. Cureus 2017;9:e1851. [PMID: 29372125 DOI: 10.7759/cureus.1851] [Reference Citation Analysis]
121 Nguyen T, Thrift AP, Yu X, Duan Z, El-Serag HB. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus. Am J Gastroenterol 2017;112:1049-55. [PMID: 28244499 DOI: 10.1038/ajg.2017.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
122 Biswas S, Quante M, Leedham S, Jansen M. The metaplastic mosaic of Barrett's oesophagus. Virchows Arch 2018;472:43-54. [PMID: 29500519 DOI: 10.1007/s00428-018-2317-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
123 Spadaccini M, Vespa E, Chandrasekar VT, Desai M, Patel HK, Maselli R, Fugazza A, Carrara S, Anderloni A, Franchellucci G, De Marco A, Hassan C, Bhandari P, Sharma P, Repici A. Advanced imaging and artificial intelligence for Barrett's esophagus: What we should and soon will do . World J Gastroenterol 2022; 28(11): 1113-1122 [DOI: 10.3748/wjg.v28.i11.1113] [Reference Citation Analysis]
124 Li N, Jin SZ. Artificial intelligence and early esophageal cancer. Artif Intell Gastrointest Endosc 2021; 2(5): 198-210 [DOI: 10.37126/aige.v2.i5.198] [Reference Citation Analysis]
125 Schwarzer S, Heidary M, Schultz J. [Painful orbital swelling in a 61-year-old female patient]. Internist (Berl) 2020;61:741-5. [PMID: 32430688 DOI: 10.1007/s00108-020-00802-3] [Reference Citation Analysis]
126 Muñoz-Largacha JA, Fernando HC, Litle VR. Optimizing the diagnosis and therapy of Barrett's esophagus. J Thorac Dis 2017;9:S146-53. [PMID: 28446978 DOI: 10.21037/jtd.2017.01.58] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
127 Garman KS, Kruger L, Thomas S, Swiderska-Syn M, Moser BK, Diehl AM, McCall SJ. Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma. Histopathology 2015;67:771-82. [PMID: 25847432 DOI: 10.1111/his.12707] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
128 Konda VJ, Cherkezyan L, Subramanian H, Wroblewski K, Damania D, Becker V, Gonzalez MH, Koons A, Goldberg M, Ferguson MK. Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening. Endoscopy. 2013;45:983-988. [PMID: 24019132 DOI: 10.1055/s-0033-1344617] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
129 Tyberg A, Choi A, Gaidhane M, Kahaleh M. Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal. Endosc Int Open. 2018;6:E549-E552. [PMID: 29756011 DOI: 10.1055/a-0584-6802] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
130 Schlottmann F, Patti MG. Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia. J Gastrointest Surg 2017;21:1354-60. [PMID: 28353175 DOI: 10.1007/s11605-017-3371-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
131 Zakko L, Visrodia K, Leggett C, Lutzke L, Wang KK. Screening patients for Barrett esophagus: Why, who, and how. Techniques in Gastrointestinal Endoscopy 2018;20:55-61. [DOI: 10.1016/j.tgie.2018.05.001] [Reference Citation Analysis]
132 Ross-Innes CS, Debiram-Beecham I, O'Donovan M, Walker E, Varghese S, Lao-Sirieix P, Lovat L, Griffin M, Ragunath K, Haidry R, Sami SS, Kaye P, Novelli M, Disep B, Ostler R, Aigret B, North BV, Bhandari P, Haycock A, Morris D, Attwood S, Dhar A, Rees C, Rutter MD, Sasieni PD, Fitzgerald RC; BEST2 Study Group. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study. PLoS Med 2015;12:e1001780. [PMID: 25634542 DOI: 10.1371/journal.pmed.1001780] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 20.6] [Reference Citation Analysis]
133 Oryu M, Mori H, Kobara H, Nishiyama N, Fujihara S, Kobayashi M, Yasuda M, Masaki T. Differences in the Characteristics of Barrett's Esophagus and Barrett's Adenocarcinoma between the United States and Japan. ISRN Gastroenterol 2013;2013:840690. [PMID: 23606979 DOI: 10.1155/2013/840690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
134 Karstens KF, Kempski J, Giannou AD, Pelczar P, Steglich B, Steurer S, Freiwald E, Woestemeier A, Konczalla L, Tachezy M, Reeh M, Bockhorn M, Perez D, Mann O, Lohse AW, Roesch T, Izbicki JR, Gagliani N, Huber S. Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival. Cancer Immunol Immunother 2020;69:1043-56. [PMID: 32100077 DOI: 10.1007/s00262-020-02517-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
135 Chang K, Jackson CS, Vega KJ. Barrett's Esophagus: Diagnosis, Management, and Key Updates. Gastroenterol Clin North Am 2021;50:751-68. [PMID: 34717869 DOI: 10.1016/j.gtc.2021.08.009] [Reference Citation Analysis]
136 O'Farrell NJ, Phelan JJ, Feighery R, Doyle B, Picardo SL, Ravi N, O'Toole D, Reynolds JV, O'Sullivan J. Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett's Esophagus Compared to Esophageal Adenocarcinoma. Int J Mol Sci 2019;20:E4449. [PMID: 31509954 DOI: 10.3390/ijms20184449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
137 Fasanella KE, Bista RK, Staton K, Rizvi S, Uttam S, Zhao C, Sepulveda A, Brand RE, McGrath K, Liu Y. Nuclear Nano-architecture Markers of Gastric Cardia and Upper Squamous Esophagus Detect Esophageal Cancer "Field Effect". J Cancer 2013;4:626-34. [PMID: 24155774 DOI: 10.7150/jca.6990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
138 Knabe M, May A, Ell C. Endoscopic Therapy of Early Carcinoma of the Oesophagus. Viszeralmedizin 2015;31:320-5. [PMID: 26989386 DOI: 10.1159/000441075] [Reference Citation Analysis]
139 Codipilly DC, Iyer PG. Novel Screening Tests for Barrett's Esophagus. Curr Gastroenterol Rep 2019;21:42. [PMID: 31346777 DOI: 10.1007/s11894-019-0710-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
140 Schoofs N, Bisschops R, Prenen H. Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview. Ann Gastroenterol. 2017;30:1-6. [PMID: 28042232 DOI: 10.20524/aog.2016.0091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
141 Choi SE, Hur C. Screening and surveillance for Barrett's esophagus: current issues and future directions. Curr Opin Gastroenterol 2012;28:377-81. [PMID: 22508325 DOI: 10.1097/MOG.0b013e328353d58e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
142 Loomans-Kropp HA, Richmond E. Undetected Barrett's esophagus: how do we improve early detection? Oncotarget 2021;12:2418-20. [PMID: 34853662 DOI: 10.18632/oncotarget.28005] [Reference Citation Analysis]
143 Huang LM, Yang WJ, Huang ZY, Tang CW, Li J. Artificial intelligence technique in detection of early esophageal cancer. World J Gastroenterol 2020; 26(39): 5959-5969 [PMID: 33132647 DOI: 10.3748/wjg.v26.i39.5959] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
144 Karstens KF, Kempski J, Giannou AD, Freiwald E, Reeh M, Tachezy M, Izbicki JR, Lohse AW, Gagliani N, Huber S, Pelczar P. Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas. PLoS One 2020;15:e0231833. [PMID: 32298379 DOI: 10.1371/journal.pone.0231833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Labenz J, Koop H, Tannapfel A, Kiesslich R, Hölscher AH. The epidemiology, diagnosis, and treatment of Barrett's carcinoma. Dtsch Arztebl Int 2015;112:224-33; quiz 234. [PMID: 25869347 DOI: 10.3238/arztebl.2015.0224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
146 Watari J, Oshima T, Fukui H, Tomita T, Miwa H. Carcinogenesis of Barrett's esophagus: a review of the clinical literature. Clin J Gastroenterol 2013;6:399-414. [PMID: 26182128 DOI: 10.1007/s12328-013-0412-z] [Reference Citation Analysis]
147 Kim HP, Bulsiewicz WJ, Cotton CC, Dellon ES, Spacek MB, Chen X, Madanick RD, Pasricha S, Shaheen NJ. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc. 2012;76:733-739. [PMID: 22732872 DOI: 10.1016/j.gie.2012.04.459] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
148 Kunze B, Wein F, Fang HY, Anand A, Baumeister T, Strangmann J, Gerland S, Ingermann J, Münch NS, Wiethaler M, Sahm V, Hidalgo-Sastre A, Lange S, Lightdale CJ, Bokhari A, Falk GW, Friedman RA, Ginsberg GG, Iyer PG, Jin Z, Nakagawa H, Shawber CJ, Nguyen T, Raab WJ, Dalerba P, Rustgi AK, Sepulveda AR, Wang KK, Schmid RM, Wang TC, Abrams JA, Quante M. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma. Gastroenterology 2020;159:575-90. [PMID: 32325086 DOI: 10.1053/j.gastro.2020.04.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
149 Pereira AD, Chaves P. Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence. United European Gastroenterol J 2016;4:343-52. [PMID: 27403300 DOI: 10.1177/2050640615612409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
150 Behrens A, May A, Manner H, Pohl J, Ell C. [Esophageal precancerous lesions: early diagnosis, treatment, and preservation of quality of life]. Internist (Berl) 2013;54:683-90. [PMID: 23657618 DOI: 10.1007/s00108-012-3212-5] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
151 Karstens KF, Stüben BO, Reeh M. Oesophageal Adenocarcinomas: Where Do We Stand Today? Cancers (Basel) 2020;13:E109. [PMID: 33396388 DOI: 10.3390/cancers13010109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Han S, Wani S. Management of low-grade dysplasia in Barrett’s esophagus: Ablate or survey? Techniques in Gastrointestinal Endoscopy 2018;20:70-4. [DOI: 10.1016/j.tgie.2018.03.001] [Reference Citation Analysis]
153 Whiteman DC. Esophageal Cancer: Priorities for Prevention. Curr Epidemiol Rep 2014;1:138-48. [DOI: 10.1007/s40471-014-0015-3] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
154 Shen C, Zhang H, Wang P, Feng J, Li J, Xu Y, Zhang A, Shao S, Yu X, Yan W, Xia Y, Hu J, Fang D. Deoxycholic acid (DCA) confers an intestinal phenotype on esophageal squamous epithelium via induction of the stemness-associated reprogramming factors OCT4 and SOX2. Cell Cycle 2016;15:1439-49. [PMID: 27096226 DOI: 10.1080/15384101.2016.1175252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
155 Kramer JR, Fischbach LA, Richardson P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Velez M, Cole R, Anand B. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett’s esophagus in white men. Clin Gastroenterol Hepatol. 2013;11:373-381.e1. [PMID: 23220167 DOI: 10.1016/j.cgh.2012.11.028] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
156 Otaki F, Iyer PG. Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile? Dig Dis Sci 2018;63:2081-93. [PMID: 29713986 DOI: 10.1007/s10620-018-5065-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
157 Wang M, Hao C, Xie S, Ma S, Ma Q, Zheng R, Chen R, Li X, Wei W. Efficacy of endoscopic treatment on patients with severe dysplasia/carcinoma in situ of esophageal squamous cell carcinoma: A prospective cohort study. Chin J Cancer Res 2019;31:357-65. [PMID: 31156306 DOI: 10.21147/j.issn.1000-9604.2019.02.10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
158 di Pietro M, Chan D, Fitzgerald RC, Wang KK. Screening for Barrett's Esophagus. Gastroenterology 2015;148:912-23. [PMID: 25701083 DOI: 10.1053/j.gastro.2015.02.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
159 Rajendra S, Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol. 2012;5:285-299. [PMID: 22973415 DOI: 10.1177/1756283x12446668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
160 Davern M, Fitzgerald MC, Buckley CE, Heeran AB, Donlon NE, McGrath J, O' Connell F, Deshpande MR, Hayes C, MacDonald J, Sheppard AD, Reynolds JV, Maher SG, Lynam-Lennon N, Murphy B, Lysaght J. PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours. Transl Oncol 2022;19:101381. [PMID: 35245832 DOI: 10.1016/j.tranon.2022.101381] [Reference Citation Analysis]
161 Streppel MM, Lata S, DelaBastide M, Montgomery EA, Wang JS, Canto MI, Macgregor-Das AM, Pai S, Morsink FH, Offerhaus GJ. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus. Oncogene. 2014;33:347-357. [PMID: 23318448 DOI: 10.1038/onc.2012.586] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
162 Freeman M, Offman J, Walter FM, Sasieni P, Smith SG. Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study. BMJ Open 2017;7:e013901. [PMID: 28255095 DOI: 10.1136/bmjopen-2016-013901] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
163 Suna N, Parlak E, Kuzu UB, Yildiz H, Koksal AS, Oztas E, Sirtas Z, Yuksel M, Aydinli O, Bilge Z, Taskiran I, Sasmaz N. The Prevalence of Barrett Esophagus Diagnosed in the Second Endoscopy: A Retrospective, Observational Study at a Tertiary Center. Medicine (Baltimore) 2016;95:e3313. [PMID: 27057907 DOI: 10.1097/MD.0000000000003313] [Reference Citation Analysis]
164 Götzel K, Chemnitzer O, Maurer L, Dietrich A, Eichfeld U, Lyros O, Moulla Y, Niebisch S, Mehdorn M, Jansen-Winkeln B, Vieth M, Hoffmeister A, Gockel I, Thieme R. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence. BMC Gastroenterol 2019;19:38. [PMID: 30841855 DOI: 10.1186/s12876-019-0957-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
165 Hyland PL, Hu N, Rotunno M, Su H, Wang C, Wang L, Pfeiffer RM, Gherman B, Giffen C, Dykes C, Dawsey SM, Abnet CC, Johnson KM, Acosta RD, Young PE, Cash BD, Taylor PR. Global changes in gene expression of Barrett's esophagus compared to normal squamous esophagus and gastric cardia tissues. PLoS One 2014;9:e93219. [PMID: 24714516 DOI: 10.1371/journal.pone.0093219] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
166 Janmaat VT, van Olphen SH, Biermann KE, Looijenga LHJ, Bruno MB, Spaander MCW. Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis. PLoS One 2017;12:e0186305. [PMID: 29059206 DOI: 10.1371/journal.pone.0186305] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
167 Martinez P, Mallo D, Paulson TG, Li X, Sanchez CA, Reid BJ, Graham TA, Kuhner MK, Maley CC. Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels. Nat Commun 2018;9:794. [PMID: 29476056 DOI: 10.1038/s41467-017-02621-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
168 Sami SS, Iyer PG. Recent Advances in Screening for Barrett's Esophagus. Curr Treat Options Gastroenterol 2018;16:1-14. [PMID: 29330747 DOI: 10.1007/s11938-018-0166-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
169 Thrift AP, Pandeya N, Whiteman DC. Current status and future perspectives on the etiology of esophageal adenocarcinoma. Front Oncol 2012;2:11. [PMID: 22655259 DOI: 10.3389/fonc.2012.00011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
170 Whitson MJ, Falk GW. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Gastroenterol Clin North Am 2015;44:299-315. [PMID: 26021196 DOI: 10.1016/j.gtc.2015.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
171 Fujiya T, Asanuma K, Koike T, Okata T, Saito M, Asano N, Imatani A, Masamune A. Nitric oxide could promote development of Barrett's esophagus by S-nitrosylation-induced inhibition of Rho-ROCK signaling in esophageal fibroblasts. Am J Physiol Gastrointest Liver Physiol 2021. [PMID: 34786954 DOI: 10.1152/ajpgi.00124.2021] [Reference Citation Analysis]
172 Sepulveda JL, Komissarova EV, Kongkarnka S, Friedman RA, Davison JM, Levy B, Bryk D, Jobanputra V, Del Portillo A, Falk GW, Sonett JR, Lightdale CJ, Abrams JA, Wang TC, Sepulveda AR. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma. Int J Cancer 2019;145:2754-66. [PMID: 31001805 DOI: 10.1002/ijc.32351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
173 Nurkin SJ, Nava HR, Yendamuri S, LeVea CM, Nwogu CE, Groman A, Wilding G, Bain AJ, Hochwald SN, Khushalani NI. Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc. 2014;28:1090-1095. [PMID: 24232046 DOI: 10.1007/s00464-013-3270-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
174 Westra WM, Straub D, Milano F, Buttar NS, Wang KK, Krishnadath KK. Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model. Dis Esophagus 2021:doab072. [PMID: 34718471 DOI: 10.1093/dote/doab072] [Reference Citation Analysis]
175 Norita K, Koike T, Saito M, Shinkai H, Ami R, Abe Y, Dairaku N, Inomata Y, Kayaba S, Ishiyama F, Oikawa T, Ohyauchi M, Ito H, Asonuma S, Hoshi T, Kato K, Ohara S, Shimodaira Y, Watanabe K, Shimosegawa T, Masamune A, Iijima K. Long-term endoscopic surveillance for Barrett's esophagus in Japan: Multicenter prospective cohort study. Dig Endosc 2021;33:1085-92. [PMID: 33277694 DOI: 10.1111/den.13910] [Reference Citation Analysis]
176 di Pietro M, Bertani H, OʼDonovan M, Santos P, Alastal H, Phillips R, Ortiz-Fernández-Sordo J, Iacucci M, Modolell I, Reggiani Bonetti L, Ragunath K, Wernisch L. Development and Validation of Confocal Endomicroscopy Diagnostic Criteria for Low-Grade Dysplasia in Barrett's Esophagus. Clin Transl Gastroenterol 2019;10:e00014. [PMID: 30985335 DOI: 10.14309/ctg.0000000000000014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 van Olphen SH, Ten Kate FJC, Doukas M, Kastelein F, Steyerberg EW, Stoop HA, Spaander MC, Looijenga LHJ, Bruno MJ, Biermann K; ProBar-Study Group. Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study. Medicine (Baltimore) 2016;95:e5402. [PMID: 27893678 DOI: 10.1097/MD.0000000000005402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
178 van Nistelrooij AM, Dinjens WN, Wagner A, Spaander MC, van Lanschot JJ, Wijnhoven BP. Hereditary Factors in Esophageal Adenocarcinoma. Gastrointest Tumors. 2014;1:93-98. [PMID: 26675496 DOI: 10.1159/000362575] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
179 Snider EJ, Kaz AM, Inadomi JM, Grady WM. Chemoprevention of esophageal adenocarcinoma. Gastroenterol Rep (Oxf) 2020;8:253-60. [PMID: 32843972 DOI: 10.1093/gastro/goaa040] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Gorospe EC, Wang KK. Barrett oesophagus in 2013: risk stratification and surveillance in Barrett oesophagus. Nat Rev Gastroenterol Hepatol 2014;11:82-4. [PMID: 24322896 DOI: 10.1038/nrgastro.2013.237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
181 Merrell AJ, Stanger BZ. Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style. Nat Rev Mol Cell Biol 2016;17:413-25. [PMID: 26979497 DOI: 10.1038/nrm.2016.24] [Cited by in Crossref: 156] [Cited by in F6Publishing: 177] [Article Influence: 26.0] [Reference Citation Analysis]
182 Pasricha S, Cotton C, Hathorn KE, Li N, Bulsiewicz WJ, Wolf WA, Muthusamy VR, Komanduri S, Wolfsen HC, Pruitt RE, Ertan A, Chmielewski GW, Shaheen NJ. Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus. Gastroenterology. 2015;149:890-6.e2. [PMID: 26116806 DOI: 10.1053/j.gastro.2015.06.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
183 Masuda A, Fujita T, Murakami M, Yamazaki Y, Kobayashi M, Terao S, Sanuki T, Okada A, Adachi M, Shiomi H, Arisaka Y, Kutsumi H, Umegaki E, Azuma T. Influence of hiatal hernia and male sex on the relationship between alcohol intake and occurrence of Barrett's esophagus. PLoS One 2018;13:e0192951. [PMID: 29447244 DOI: 10.1371/journal.pone.0192951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
184 Koulis A, Buckle A, Boussioutas A. Premalignant lesions and gastric cancer: Current understanding. World J Gastrointest Oncol 2019; 11(9): 665-678 [PMID: 31558972 DOI: 10.4251/wjgo.v11.i9.665] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
185 Domper Arnal MJ, Ferrández Arenas &, Lanas Arbeloa &. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015; 21(26): 7933-7943 [PMID: 26185366 DOI: 10.3748/wjg.v21.i26.7933] [Cited by in CrossRef: 363] [Cited by in F6Publishing: 342] [Article Influence: 51.9] [Reference Citation Analysis]
186 Shen K, Zhang S, Ma S, Zhang H. Molecular Markers and Diagnostic Model Specific for Barrett's Esophagus. J Comput Biol 2019;26:1367-78. [PMID: 31259619 DOI: 10.1089/cmb.2019.0064] [Reference Citation Analysis]
187 Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28:2323-2333. [PMID: 24562599 DOI: 10.1007/s00464-014-3461-6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]
188 Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012;9:278-287. [PMID: 22430857 DOI: 10.1038/nrclinonc.2012.35] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 7.8] [Reference Citation Analysis]
189 Nguyen TH, Thrift AP, Ketwaroo GA, Du XL, Leon Novelo L, George R, Rosen DG, El-Serag HB. External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc 2022:S0016-5107(22)00002-5. [PMID: 34998796 DOI: 10.1016/j.gie.2021.12.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Gora MJ, Simmons LH, Quénéhervé L, Grant CN, Carruth RW, Lu W, Tiernan A, Dong J, Walker-Corkery B, Soomro A, Rosenberg M, Metlay JP, Tearney GJ. Tethered capsule endomicroscopy: from bench to bedside at a primary care practice.J Biomed Opt. 2016;21:104001. [PMID: 27689919 DOI: 10.1117/1.Jbo.21.10.104001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
191 Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol. 2017;112:1247-1255. [PMID: 28585555 DOI: 10.1038/ajg.2017.155] [Cited by in Crossref: 141] [Cited by in F6Publishing: 118] [Article Influence: 28.2] [Reference Citation Analysis]
192 Snider EJ, Freedberg DE, Abrams JA. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci. 2016;61:2217-2225. [PMID: 27068172 DOI: 10.1007/s10620-016-4155-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
193 Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015;110:662-682; quiz 683. [PMID: 25869390 DOI: 10.1038/ajg.2015.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 11.4] [Reference Citation Analysis]
194 Zhang T, Wang Q, Ma WY, Wang K, Chang X, Johnson ML, Bai R, Bode AM, Foster NR, Falk GW, Limburg PJ, Iyer PG, Dong Z. Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development. EBioMedicine 2019;49:145-56. [PMID: 31707149 DOI: 10.1016/j.ebiom.2019.10.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Harada K, Rogers JE, Iwatsuki M, Yamashita K, Baba H, Ajani JA. Recent advances in treating oesophageal cancer. F1000Res 2020;9:F1000 Faculty Rev-1189. [PMID: 33042518 DOI: 10.12688/f1000research.22926.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Arnold M, Colquhoun A, Cook MB, Ferlay J, Forman D, Soerjomataram I. Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. Cancer Epidemiol Biomarkers Prev 2016;25:90-7. [PMID: 26494763 DOI: 10.1158/1055-9965.EPI-15-0753] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
197 Kosovec JE, Zaidi AH, Pounardjian TS, Jobe BA. The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy. Front Oncol 2018;8:610. [PMID: 30619750 DOI: 10.3389/fonc.2018.00610] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
198 Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol 2013; 19(34): 5598-5606 [PMID: 24039351 DOI: 10.3748/wjg.v19.i34.5598] [Cited by in CrossRef: 533] [Cited by in F6Publishing: 521] [Article Influence: 59.2] [Reference Citation Analysis]
199 Lopes CAM, Mesquita M, Cunha AI, Cardoso J, Carapeta S, Laranjeira C, Pinto AE, Pereira-Leal JB, Dias-Pereira A, Bettencourt-Dias M, Chaves P. Centrosome amplification arises before neoplasia and increases upon p53 loss in tumorigenesis. J Cell Biol 2018;217:2353-63. [PMID: 29739803 DOI: 10.1083/jcb.201711191] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 8.8] [Reference Citation Analysis]
200 Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB; UK RFA Registry. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 2015;64:1192-9. [PMID: 25539672 DOI: 10.1136/gutjnl-2014-308501] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
201 Li X, Paulson TG, Galipeau PC, Sanchez CA, Liu K, Kuhner MK, Maley CC, Self SG, Vaughan TL, Reid BJ, Blount PL. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus. Cancer Prev Res (Phila). 2015;8:845-856. [PMID: 26130253 DOI: 10.1158/1940-6207.capr-15-0130] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
202 Mandrioli D, Belpoggi F, Silbergeld EK, Perry MJ. Aneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicants. Environ Health 2016;15:97. [PMID: 27729050 DOI: 10.1186/s12940-016-0180-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
203 Chettouh H, Mowforth O, Galeano-Dalmau N, Bezawada N, Ross-Innes C, MacRae S, Debiram-Beecham I, O'Donovan M, Fitzgerald RC. Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens. Gut 2018;67:1942-9. [PMID: 29084829 DOI: 10.1136/gutjnl-2017-314026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
204 Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Barrett’s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther 2016; 7(2): 190-206 [PMID: 27158534 DOI: 10.4292/wjgpt.v7.i2.190] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
205 Bucchi D, Stracci F, Buonora N, Masanotti G. Human papillomavirus and gastrointestinal cancer: A review. World J Gastroenterol 2016; 22(33): 7415-7430 [PMID: 27672265 DOI: 10.3748/wjg.v22.i33.7415] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
206 Hong J, Li D, Cao W. Rho Kinase ROCK2 Mediates Acid-Induced NADPH Oxidase NOX5-S Expression in Human Esophageal Adenocarcinoma Cells. PLoS One 2016;11:e0149735. [PMID: 26901778 DOI: 10.1371/journal.pone.0149735] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
207 Laßmann S, Werner M. Are caudal-type homeobox genes causal for gastro-esophageal reflux disease and Barrett's esophagus? Dig Dis Sci 2014;59:16-8. [PMID: 24052194 DOI: 10.1007/s10620-013-2861-0] [Reference Citation Analysis]
208 Smyth EC, Cunningham D. Operable gastro-oesophageal junctional adenocarcinoma: Where to next? World J Gastrointest Oncol 2014; 6(6): 145-155 [PMID: 24936225 DOI: 10.4251/wjgo.v6.i6.145] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
209 Kumar S, Iyer PG. Endoscopic eradication therapy for Barrett’s esophagus: Adverse outcomes, patient values, and cost-effectiveness. Techniques in Gastrointestinal Endoscopy 2018;20:75-81. [DOI: 10.1016/j.tgie.2018.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
210 Butt J, Kandel G. Barrett esophagus: when to endoscope. Clin Endosc 2014;47:40-6. [PMID: 24570882 DOI: 10.5946/ce.2014.47.1.40] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
211 Campos VJ, Mazzini GS, Juchem JF, Gurski RR. Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study. J Gastrointest Surg 2020;24:8-18. [PMID: 31745889 DOI: 10.1007/s11605-019-04456-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
212 Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SR. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases. J Gastrointest Surg 2017;21:62-7. [PMID: 27561633 DOI: 10.1007/s11605-016-3210-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
213 Bennett C, Green S, DeCaestecker J, Almond M, Barr H, Bhandari P, Ragunath K, Singh R, Jankowski J. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus. Cochrane Database Syst Rev 2020;5:CD007334. [PMID: 32442322 DOI: 10.1002/14651858.CD007334.pub5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
214 di Pietro M, Boerwinkel DF, Shariff MK, Liu X, Telakis E, Lao-Sirieix P, Walker E, Couch G, Mills L, Nuckcheddy-Grant T, Slininger S, O'Donovan M, Visser M, Meijer SL, Kaye PV, Wernisch L, Ragunath K, Bergman JJ, Fitzgerald RC. The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus. Gut 2015;64:49-56. [PMID: 24721904 DOI: 10.1136/gutjnl-2013-305975] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
215 De Silva N, Fitzgerald R. Barrett's oesophagus and oesophageal adenocarcinoma. Medicine 2015;43:202-9. [DOI: 10.1016/j.mpmed.2015.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
216 Janmaat VT, Van De Winkel A, Peppelenbosch MP, Spaander MC, Uitterlinden AG, Pourfarzad F, Tilanus HW, Rygiel AM, Moons LM, Arp PP. Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk. Mol Med. 2015;21:346-354. [PMID: 25910066 DOI: 10.2119/molmed.2012.00336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
217 Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.Gastroenterology. 2020;158:527-536.e7. [PMID: 31654635 DOI: 10.1053/j.gastro.2019.10.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
218 Zhang X, Westerhoff M, Hart J. Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up. Mod Pathol 2015;28:654-61. [PMID: 25412842 DOI: 10.1038/modpathol.2014.157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
219 Orditura M, Galizia G, Lieto E, De Vita F, Ciardiello F. Treatment of esophagogastric junction carcinoma: An unsolved debate. World J Gastroenterol 2015; 21(15): 4427-4431 [PMID: 25914451 DOI: 10.3748/wjg.v21.i15.4427] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
220 Rugge M, Pizzi M, Castoro C. Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg 2015;39:559-65. [PMID: 25015727 DOI: 10.1007/s00268-014-2692-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
221 Yano T. What is the next critical finding to change our mind in esophagogastroduodenoscopy? Dig Endosc 2021. [PMID: 34859499 DOI: 10.1111/den.14196] [Reference Citation Analysis]
222 Del Portillo A, Lagana SM, Yao Y, Uehara T, Jhala N, Ganguly T, Nagy P, Gutierrez J, Luna A, Abrams J, Liu Y, Brand R, Sepulveda JL, Falk GW, Sepulveda AR. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus. J Mol Diagn 2015;17:412-9. [PMID: 26068095 DOI: 10.1016/j.jmoldx.2015.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
223 Choi SE, Perzan KE, Tramontano AC, Kong CY, Hur C. Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. Cancer Prev Res (Phila) 2014;7:341-50. [PMID: 24380852 DOI: 10.1158/1940-6207.CAPR-13-0191-T] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
224 Nelsen EM, Hawes RH, Iyer PG. Diagnosis and management of Barrett's esophagus. Surg Clin North Am 2012;92:1135-54. [PMID: 23026274 DOI: 10.1016/j.suc.2012.07.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
225 Dhaliwal A, Saghir SM, Mashiana HS, Braseth A, Dhindsa BS, Ramai D, Taunk P, Gomez-Esquivel R, Dam A, Klapman J, Adler DG. Endoscopic cryotherapy: Indications, techniques, and outcomes involving the gastrointestinal tract. World J Gastrointest Endosc 2022; 14(1): 17-28 [DOI: 10.4253/wjge.v14.i1.17] [Reference Citation Analysis]
226 Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, Diehl AM, Provenzale D, Shaheen NJ. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer. Dig Dis Sci. 2013;58:3178-3188. [PMID: 23925817 DOI: 10.1007/s10620-013-2806-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
227 Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol 2016; 22(5): 1800-1810 [PMID: 26855539 DOI: 10.3748/wjg.v22.i5.1800] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
228 Okereke IC, Miller AL, Jupiter DC, Hamilton CF, Reep GL, Krill T, Andersen CR, Pyles RB. Microbiota Detection Patterns Correlate With Presence and Severity of Barrett's Esophagus. Front Cell Infect Microbiol 2021;11:555072. [PMID: 33708643 DOI: 10.3389/fcimb.2021.555072] [Reference Citation Analysis]
229 Zhao Q, Hu F, Xiao Z, Li M, Wu X, Zhao Y, Wu Y, Yin J, Lin L, Zhang H, Zhang L, Cho CH, Shen J. Comprehensive molecular profiling of the B7 family in gastrointestinal cancer. Cell Prolif 2018;51:e12468. [PMID: 29999557 DOI: 10.1111/cpr.12468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
230 Sun X, Elston RC, Barnholtz-Sloan JS, Falk GW, Grady WM, Faulx A, Mittal SK, Canto M, Shaheen NJ, Wang JS, Iyer PG, Abrams JA, Tian YD, Willis JE, Guda K, Markowitz SD, Chandar A, Warfe JM, Brock W, Chak A. Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm. Cancer Epidemiol Biomarkers Prev 2016;25:727-35. [PMID: 26929243 DOI: 10.1158/1055-9965.EPI-15-0832] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
231 Bhardwaj A, McGarrity TJ, Stairs DB, Mani H. Barrett's Esophagus: Emerging Knowledge and Management Strategies. Patholog Res Int. 2012;2012:814146. [PMID: 22701199 DOI: 10.1155/2012/814146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
232 von Holzen U, Enders GH. A surprise cell of origin for Barrett's esophagus. Cancer Biol Ther. 2012;13:588-591. [PMID: 22549156 DOI: 10.4161/cbt.20088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
233 O'Donovan M, Fitzgerald RC. Screening for Barrett's Esophagus: Are New High-Volume Methods Feasible? Dig Dis Sci 2018;63:2105-14. [PMID: 29995243 DOI: 10.1007/s10620-018-5192-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
234 Deshpande NP, Riordan SM, Castaño-Rodríguez N, Wilkins MR, Kaakoush NO. Signatures within the esophageal microbiome are associated with host genetics, age, and disease. Microbiome 2018;6:227. [PMID: 30558669 DOI: 10.1186/s40168-018-0611-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
235 Kamboj AK, Katzka DA, Iyer PG. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. Gastrointest Endosc Clin N Am 2021;31:27-41. [PMID: 33213798 DOI: 10.1016/j.giec.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Kallam A, Alsop BR, Sharma P. Limitations of endoscopic ablation in Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2015;9:487-96. [PMID: 25483982 DOI: 10.1586/17474124.2015.976554] [Reference Citation Analysis]
237 Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, Realdon S, Battaglia G, Souza R, Odze RD. MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. Clin Transl Gastroenterol. 2013;4:e34. [PMID: 23677165 DOI: 10.1038/ctg.2013.5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
238 Li D, Cao W. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2014;306:G863-72. [PMID: 24699332 DOI: 10.1152/ajpgi.00321.2013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
239 Grille VJ, Campbell S, Gibbs JF, Bauer TL. Esophageal cancer: the rise of adenocarcinoma over squamous cell carcinoma in the Asian belt. J Gastrointest Oncol 2021;12:S339-49. [PMID: 34422398 DOI: 10.21037/jgo-2019-gi-08] [Reference Citation Analysis]
240 von Dercks N, Gockel I, Mehdorn M, Lorenz D. [Economic aspects of oncological esophageal surgery : Centralization is essential]. Chirurg 2017;88:62-9. [PMID: 27882394 DOI: 10.1007/s00104-016-0326-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
241 Tomizawa Y, Iyer PG, Wong Kee Song LM, Buttar NS, Lutzke LS, Wang KK. Safety of endoscopic mucosal resection for Barrett's esophagus. Am J Gastroenterol. 2013;108:1440-147; quiz 1448. [PMID: 23857478 DOI: 10.1038/ajg.2013.187] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
242 Derouet MF, Liu G, Darling GE. MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance. PLoS One. 2014;9:e115589. [PMID: 25551563 DOI: 10.1371/journal.pone.0115589] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
243 Shadfan A, Hellebust A, Richards-Kortum R, Tkaczyk T. Confocal foveated endomicroscope for the detection of esophageal carcinoma. Biomed Opt Express 2015;6:2311-24. [PMID: 26203363 DOI: 10.1364/BOE.6.002311] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
244 Kong CY, Kroep S, Curtius K, Hazelton WD, Jeon J, Meza R, Heberle CR, Miller MC, Choi SE, Lansdorp-Vogelaar I, van Ballegooijen M, Feuer EJ, Inadomi JM, Hur C, Luebeck EG. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomarkers Prev 2014;23:997-1006. [PMID: 24692500 DOI: 10.1158/1055-9965.EPI-13-1233] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
245 Haider SH, Kwon S, Lam R, Lee AK, Caraher EJ, Crowley G, Zhang L, Schwartz TM, Zeig-Owens R, Liu M, Prezant DJ, Nolan A. Predictive Biomarkers of Gastroesophageal Reflux Disease and Barrett's Esophagus in World Trade Center Exposed Firefighters: a 15 Year Longitudinal Study. Sci Rep 2018;8:3106. [PMID: 29449669 DOI: 10.1038/s41598-018-21334-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
246 Sawyer JK, Cohen E, Fox DT. Interorgan regulation of Drosophila intestinal stem cell proliferation by a hybrid organ boundary zone. Development 2017;144:4091-102. [PMID: 28947534 DOI: 10.1242/dev.153114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
247 Daans CG, Ghorbanoghli Z, Velthuizen ME, Vasen HFA, Offerhaus GJA, Lacle MM, Siersema PD, Ausems MGEM, Boonstra JJ. Increased prevalence of Barrett's esophagus in patients with MUTYH-associated polyposis (MAP). Fam Cancer 2020;19:183-7. [PMID: 32088803 DOI: 10.1007/s10689-020-00162-9] [Reference Citation Analysis]
248 Shiota S, El-Serag HB, Thrift AP. Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci 2016;61:1139-47. [PMID: 26611860 DOI: 10.1007/s10620-015-3967-3] [Reference Citation Analysis]
249 Fujii-Lau LL, Cinnor B, Shaheen N, Gaddam S, Komanduri S, Muthusamy VR, Das A, Wilson R, Simon VC, Kushnir V, Mullady D, Edmundowicz SA, Early DS, Wani S. Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis. Endosc Int Open 2017;5:E430-49. [PMID: 28573176 DOI: 10.1055/s-0043-106578] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
250 Shiota S, Singh S, Anshasi A, El-Serag HB. Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2015;13:1907-1918. [PMID: 26260107 DOI: 10.1016/j.cgh.2015.07.050] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
251 Dolak W, Mesteri I, Asari R, Preusser M, Tribl B, Wrba F, Schoppmann SF, Hejna M, Trauner M, Häfner M, Püspök A. A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resection. Endosc Int Open 2015;3:E19-28. [PMID: 26134766 DOI: 10.1055/s-0034-1377935] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
252 Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, Corley D, El-Serag H, Falk GW, Fitzgerald R. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015;149:1599-1606. [PMID: 26296479 DOI: 10.1053/j.gastro.2015.08.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
253 Furneri G, Klausnitzer R, Haycock L, Ihara Z. Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model. PLoS One 2019;14:e0212916. [PMID: 30865673 DOI: 10.1371/journal.pone.0212916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
254 Quante M, Abrams JA, Lee Y, Wang TC. Barrett esophagus: what a mouse model can teach us about human disease. Cell Cycle. 2012;11:4328-4338. [PMID: 23095673 DOI: 10.4161/cc.22485] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
255 Matsuzaki J, Suzuki H. MicroRNAs in Barrett's esophagus: future prospects. Front Genet 2014;5:69. [PMID: 24765103 DOI: 10.3389/fgene.2014.00069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
256 Vance RB, Dunbar KB. Endoscopic options for treatment of dysplasia in Barrett’s esophagus. World J Gastrointest Endosc 2015; 7(19): 1311-1317 [PMID: 26722612 DOI: 10.4253/wjge.v7.i19.1311] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
257 Lochhead P, Chan AT. Screening and surveillance for Barrett esophagus. JAMA Intern Med 2015;175:159-60. [PMID: 25546002 DOI: 10.1001/jamainternmed.2014.6983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
258 Dunne MR, Michielsen AJ, O'Sullivan KE, Cathcart MC, Feighery R, Doyle B, Watson JA, O'Farrell NJ, Ravi N, Kay E, Reynolds JV, Ryan EJ, O'Sullivan J. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients. Cancer Immunol Immunother 2017;66:841-50. [PMID: 28315927 DOI: 10.1007/s00262-017-1983-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
259 Naini BV, Souza RF, Odze RD. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol. 2016;40:e45-e66. [PMID: 26813745 DOI: 10.1097/pas.0000000000000598] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
260 Li H, Jasper H. Gastrointestinal stem cells in health and disease: from flies to humans. Dis Model Mech 2016;9:487-99. [PMID: 27112333 DOI: 10.1242/dmm.024232] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 13.7] [Reference Citation Analysis]
261 Hao W, Shen Y, Feng M, Wang H, Lin M, Fang Y, Tan L. Aspirin acts in esophageal cancer: a brief review. J Thorac Dis 2018;10:2490-7. [PMID: 29850157 DOI: 10.21037/jtd.2018.03.110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
262 Offman J, Pesola F, Sasieni P. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037. Br J Cancer 2018;118:1391-8. [PMID: 29563637 DOI: 10.1038/s41416-018-0047-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
263 Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2015;13:84-90. [PMID: 24681073 DOI: 10.1016/j.cgh.2014.03.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
264 Delman AM, Ammann AM, Turner KM, Vaysburg DM, Van Haren RM. A narrative review of socioeconomic disparities in the treatment of esophageal cancer. J Thorac Dis 2021;13:3801-8. [PMID: 34277070 DOI: 10.21037/jtd-20-3095] [Reference Citation Analysis]
265 Duits LC, Lao-Sirieix P, Wolf WA, O'Donovan M, Galeano-Dalmau N, Meijer SL, Offerhaus GJA, Redman J, Crawte J, Zeki S, Pouw RE, Chak A, Shaheen NJ, Bergman JJGHM, Fitzgerald RC. A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma. Dis Esophagus. 2019;32. [PMID: 30496496 DOI: 10.1093/dote/doy102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
266 de Groof J, van der Sommen F, van der Putten J, Struyvenberg MR, Zinger S, Curvers WL, Pech O, Meining A, Neuhaus H, Bisschops R, Schoon EJ, de With PH, Bergman JJ. The Argos project: The development of a computer-aided detection system to improve detection of Barrett's neoplasia on white light endoscopy. United European Gastroenterol J. 2019;7:538-547. [PMID: 31065371 DOI: 10.1177/2050640619837443] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 15.3] [Reference Citation Analysis]
267 Nguyen TH, Thrift AP, Rugge M, El-Serag HB. Prevalence of Barrett's esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc 2021;93:409-419.e1. [PMID: 32565183 DOI: 10.1016/j.gie.2020.06.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
268 Testa U, Castelli G, Pelosi E. Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution. Medicines (Basel) 2017;4:E67. [PMID: 28930282 DOI: 10.3390/medicines4030067] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
269 Stier MW, Konda VJ, Hart J, Waxman I. Post-ablation surveillance in Barrett's esophagus: A review of the literature. World J Gastroenterol 2016; 22(17): 4297-4306 [PMID: 27158198 DOI: 10.3748/wjg.v22.i17.4297] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
270 Newberry C, Lynch K. Using Diet to Treat Diseases of Esophagus: Back to the Basics. Gastroenterol Clin North Am 2021;50:959-72. [PMID: 34717881 DOI: 10.1016/j.gtc.2021.08.008] [Reference Citation Analysis]
271 Di J, Sharma N, Pérez LKM, Zhang J, Ho KY. Surveillance strategy of Barrett's esophagus in the Asian region with particular reference to its locoregional epidemiology. JGH Open 2020;4:565-8. [PMID: 32782939 DOI: 10.1002/jgh3.12350] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
272 Zakko L, Visrodia K, Wang KK, Iyer PG. Editorial: The Effect of Bias on Estimation of Improved Survival After Diagnosis of Barrett's Esophagus. Am J Gastroenterol 2017;112:1265-6. [PMID: 28766563 DOI: 10.1038/ajg.2017.185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
273 Chedgy FJ, Kandiah K, Thayalasekaran S, Subramaniam S, Bhandari P. Advances in the endoscopic diagnosis and treatment of Barrett's neoplasia. F1000Res 2016;5:F1000 Faculty Rev-113. [PMID: 26918175 DOI: 10.12688/f1000research.6996.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
274 Napier KJ, Scheerer M, Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014; 6(5): 112-120 [PMID: 24834141 DOI: 10.4251/wjgo.v6.i5.112] [Cited by in CrossRef: 373] [Cited by in F6Publishing: 355] [Article Influence: 46.6] [Reference Citation Analysis]
275 Desai M, Lieberman DA, Kennedy KF, Hamade N, Thota P, Parasa S, Gorrepati VS, Bansal A, Gupta N, Gaddam S, Young PE, Mathur S, Moawad FJ, Cash BD, Sampliner R, Vargo JJ, Falk GW, Sharma P. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium. Gastrointest Endosc 2019;89:257-263.e3. [PMID: 30342028 DOI: 10.1016/j.gie.2018.09.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
276 Laine L, Nagar A. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits. Am J Gastroenterol 2016;111:913-5. [PMID: 27113114 DOI: 10.1038/ajg.2016.156] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
277 Yun T, Liu Y, Gao D, Linghu E, Brock MV, Yin D, Zhan Q, Herman JG, Guo M. Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel. Genes Cancer 2015;6:38-48. [PMID: 25821560 DOI: 10.18632/genesandcancer.46] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
278 Sulahian R, Chen J, Arany Z, Jadhav U, Peng S, Rustgi AK, Bass AJ, Srivastava A, Hornick JL, Shivdasani RA. SOX15 governs transcription in human stratified epithelia and a subset of esophageal adenocarcinomas. Cell Mol Gastroenterol Hepatol 2015;1:598-609.e6. [PMID: 26516633 DOI: 10.1016/j.jcmgh.2015.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
279 Ortega Deballon P. Indications for anti-reflux surgery in Barrett's esophagus. Cir Esp 2015;93:270-1. [PMID: 25616742 DOI: 10.1016/j.ciresp.2014.12.001] [Reference Citation Analysis]
280 Vergara D, Simeone P, Damato M, Maffia M, Lanuti P, Trerotola M. The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression. J Oncol 2019;2019:1253727. [PMID: 31772577 DOI: 10.1155/2019/1253727] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
281 Molendijk J, Nguyen TM, Brown I, Mohamed A, Lim Y, Barclay J, Hodson MP, Hennessy TP, Krause L, Morrison M, Hill MM. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling. Biomolecules 2020;10:E776. [PMID: 32429496 DOI: 10.3390/biom10050776] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
282 Smith MS, Ikonomi E, Bhuta R, Iorio N, Kataria RD, Kaul V, Gross SA; US Collaborative WATS Study Group . Wide-area transepithelial sampling with computer-assisted 3-dimensional analysis (WATS) markedly improves detection of esophageal dysplasia and Barrett's esophagus: analysis from a prospective multicenter community-based study. Dis Esophagus 2019;32:doy099. [PMID: 30541019 DOI: 10.1093/dote/doy099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
283 Yang Y, Chen H, Wang R, Tang Y, Chen X. Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening. Medicine 2015;94:e1563. [DOI: 10.1097/md.0000000000001563] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
284 Spechler SJ, Merchant JL, Wang TC, Chandrasoma P, Fox JG, Genta RM, Goldenring JR, Hayakawa Y, Kuipers EJ, Lund PK, McKeon F, Mills JC, Odze RD, Peek RM Jr, Pham T, Que J, Rustgi AK, Shaheen NJ, Shivdasani RA, Souza RF, Storz P, Todisco A, Wang DH, Wright NA. A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance. Gastroenterology 2017;153:e6-e13. [PMID: 28583825 DOI: 10.1053/j.gastro.2017.05.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
285 Meves V, Behrens A, Pohl J. Diagnostics and Early Diagnosis of Esophageal Cancer. Viszeralmedizin 2015;31:315-8. [PMID: 26989385 DOI: 10.1159/000439473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
286 Kim JH. Significance of Persistent Nondysplasia Over Multiple Endoscopic Surveillance in Risk Stratification of Patients With Barrett's Esophagus (Gastroenterology 2013;145:548-553, e1). J Neurogastroenterol Motil 2013;19:542-3. [PMID: 24199018 DOI: 10.5056/jnm.2013.19.4.542] [Reference Citation Analysis]
287 Hammoud GM, Hammad H, Ibdah JA. Endoscopic assessment and management of early esophageal adenocarcinoma. World J Gastrointest Oncol 2014; 6(8): 275-288 [PMID: 25132925 DOI: 10.4251/wjgo.v6.i8.275] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
288 Nam SY. Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver 2017;11:323-34. [PMID: 27890867 DOI: 10.5009/gnl15557] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
289 van Olphen S, Biermann K, Spaander MC, Kastelein F, Steyerberg EW, Stoop HA, Bruno MJ, Looijenga LH. SOX2 as a novel marker to predict neoplastic progression in Barrett's esophagus. Am J Gastroenterol. 2015;110:1420-1428. [PMID: 26323187 DOI: 10.1038/ajg.2015.260] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
290 Sayin SI, Baumeister T, Wang TC, Quante M. Origins of Metaplasia in the Esophagus: Is This a GE Junction Stem Cell Disease? Dig Dis Sci 2018;63:2013-21. [PMID: 29948557 DOI: 10.1007/s10620-018-5152-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
291 Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, Granderath F, Horvath P, Kardos P, Pointner R, Savarino E, Van Herwaarden-Lindeboom M, Zaninotto G;  European Association of Endoscopic Surgery (EAES). EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753-1773. [PMID: 24789125 DOI: 10.1007/s00464-014-3431-z] [Cited by in Crossref: 108] [Cited by in F6Publishing: 70] [Article Influence: 13.5] [Reference Citation Analysis]
292 Schlottmann F, Patti MG, Shaheen NJ. From Heartburn to Barrett's Esophagus, and Beyond. World J Surg 2017;41:1698-704. [PMID: 28258457 DOI: 10.1007/s00268-017-3957-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
293 Curtius K, Wong CJ, Hazelton WD, Kaz AM, Chak A, Willis JE, Grady WM, Luebeck EG. A Molecular Clock Infers Heterogeneous Tissue Age Among Patients with Barrett's Esophagus. PLoS Comput Biol 2016;12:e1004919. [PMID: 27168458 DOI: 10.1371/journal.pcbi.1004919] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
294 Gatenby P, Soon Y. Barrett’s oesophagus: Evidence from the current meta-analyses. World J Gastrointest Pathophysiol 2014; 5(3): 178-187 [PMID: 25133020 DOI: 10.4291/wjgp.v5.i3.178] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
295 Hardikar S, Onstad L, Song X, Wilson AM, Montine TJ, Kratz M, Anderson GL, Blount PL, Reid BJ, White E, Vaughan TL. Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort. Cancer Epidemiol Biomarkers Prev 2014;23:2393-403. [PMID: 25106775 DOI: 10.1158/1055-9965.EPI-14-0384] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
296 Frankel A, Nancarrow D, Wayte N, Barbour A. Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key? ANZ J Surg 2012;82:599-606. [PMID: 22856687 DOI: 10.1111/j.1445-2197.2012.06144.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
297 Ishihara R, Yamamoto S, Hanaoka N, Takeuchi Y, Higashino K, Uedo N, Iishi H. Endoscopic submucosal dissection for superficial Barrett's esophageal cancer in the Japanese state and perspective. Ann Transl Med 2014;2:24. [PMID: 25333000 DOI: 10.3978/j.issn.2305-5839.2014.02.03] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
298 Reid BJ, Paulson TG, Li X. Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2015;149:1142-1152.e3. [PMID: 26208895 DOI: 10.1053/j.gastro.2015.07.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
299 Morrow E, Bushyhead D, Wassenaar E, Hinojosa M, Loviscek M, Pellegrini C, Oelschlager B. The impact of laparoscopic anti-reflux surgery in patients with Barrett’s esophagus. Surg Endosc. 2014;28:3279-3284. [PMID: 24935200 DOI: 10.1007/s00464-014-3601-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
300 Max Almond L, Barr H. Management controversies in Barrett’s oesophagus. J Gastroenterol. 2013;Jun 5; Epub ahead of print. [PMID: 23736794 DOI: 10.1007/s00535-013-0816-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
301 Wilson H, Mocanu V, Sun W, Dang J, Jogiat U, Kung J, Switzer N, Wong C, Karmali S. Fundoplication is superior to medical therapy for Barrett's esophagus disease regression and progression: a systematic review and meta-analysis. Surg Endosc 2021. [PMID: 34008109 DOI: 10.1007/s00464-021-08543-6] [Reference Citation Analysis]
302 Matsuzaki J, Suzuki H. Circulating microRNAs as potential biomarkers to detect transformation of Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open Gastroenterol 2017;4:e000160. [PMID: 29177063 DOI: 10.1136/bmjgast-2017-000160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
303 Bureo Gonzalez A, Bergman JJ, Pouw RE. Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus. United European Gastroenterol J 2016;4:657-62. [PMID: 27733907 DOI: 10.1177/2050640616635509] [Reference Citation Analysis]
304 Sharma N, Srivastava S, Kern F, Xian W, Ming T, McKeon F, Ho KY. Endoscopic modalities for the diagnosis of Barrett's oesophagus. United European Gastroenterol J 2016;4:733-40. [PMID: 28408990 DOI: 10.1177/2050640615619281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
305 Sami SS, Ragunath K, Iyer PG. Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions. Clin Gastroenterol Hepatol 2015;13:623-34. [PMID: 24887058 DOI: 10.1016/j.cgh.2014.03.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
306 Gockel I, Hoffmeister A. Endoscopic or Surgical Resection for Gastro-Esophageal Cancer. Dtsch Arztebl Int 2018;115:513-9. [PMID: 30149830 DOI: 10.3238/arztebl.2018.0513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
307 Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA. Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses. Dig Dis Sci 2019;64:1089-97. [PMID: 30911864 DOI: 10.1007/s10620-019-05586-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
308 Cass S, Hamilton C, Miller A, Jupiter D, Khanipov K, Booth A, Pyles R, Krill T, Reep G, Okereke I. Novel Ex Vivo Model to Examine the Mechanism and Relationship of Esophageal Microbiota and Disease. Biomedicines 2021;9:142. [PMID: 33540531 DOI: 10.3390/biomedicines9020142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
309 Lordick F, Hölscher AH, Haustermans K, Wittekind C. Multimodal treatment of esophageal cancer. Langenbecks Arch Surg 2013;398:177-87. [PMID: 22971784 DOI: 10.1007/s00423-012-1001-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
310 di Pietro M, Fitzgerald RC. Research advances in esophageal diseases: bench to bedside. F1000Prime Rep. 2013;5:44. [PMID: 24167725 DOI: 10.12703/p5-44] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
311 Thomas T, Loke Y, Beales ILP. Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma. J Gastrointest Cancer 2018;49:442-54. [PMID: 28691139 DOI: 10.1007/s12029-017-9983-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
312 Westerveld D, Khullar V, Mramba L, Ayoub F, Brar T, Agarwal M, Forde J, Chakraborty J, Riverso M, Perbtani YB, Gupte A, Forsmark CE, Draganov P, Yang D. Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis. Endosc Int Open 2018;6:E300-7. [PMID: 29507870 DOI: 10.1055/s-0044-101351] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
313 Cai Y, Wang J. Significant association of glutathione S-transferase T1 null genotype with esophageal cancer risk: a meta-analysis. Mol Biol Rep. 2013;40:2397-2403. [PMID: 23238916 DOI: 10.1007/s11033-012-2320-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
314 Huntington JT, Walker JP, Meara MP, Hazey JW, Melvin WS, Perry KA. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience. Surg Endosc 2015;29:2121-5. [PMID: 25472745 DOI: 10.1007/s00464-014-3962-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
315 Kang SH, Lim Y, Lee H, Kim J, Chi S, Min YW, Min BH, Lee JH, Son HJ, Ryu S, Rhee PL, Kim JJ. A Model for Predicting the Future Risk of Incident Erosive Esophagitis in an Asymptomatic Population Undergoing Regular Check-ups. Medicine (Baltimore) 2016;95:e2591. [PMID: 26825906 DOI: 10.1097/MD.0000000000002591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
316 Palma GDD. Management strategies of Barrett's esophagus. World J Gastroenterol 2012; 18(43): 6216-6225 [PMID: 23180941 DOI: 10.3748/wjg.v18.i43.6216] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
317 Old OJ, Almond LM, Barr H. Barrett's oesophagus: how should we manage it? Frontline Gastroenterol 2015;6:108-16. [PMID: 28839797 DOI: 10.1136/flgastro-2014-100552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
318 Lenglinger J, See SF, Beller L, Cosentini EP, Asari R, Wrba F, Riegler M, Schoppmann SF. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr 2013;125:577-90. [PMID: 24061694 DOI: 10.1007/s00508-013-0418-z] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
319 Michopoulos S. Critical appraisal of guidelines for screening and surveillance of Barrett's esophagus. Ann Transl Med 2018;6:259. [PMID: 30094245 DOI: 10.21037/atm.2018.05.09] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
320 Thrift AP, Kramer JR, Richardson PA, El-Serag HB. No significant effects of smoking or alcohol consumption on risk of Barrett’s esophagus. Dig Dis Sci. 2014;59:108-116. [PMID: 24114046 DOI: 10.1007/s10620-013-2892-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
321 Okereke I, Hamilton C, Reep G, Krill T, Booth A, Ghouri Y, Jala V, Andersen C, Pyles R. Microflora composition in the gastrointestinal tract in patients with Barrett's esophagus. J Thorac Dis. 2019;11:S1581-S1587. [PMID: 31489224 DOI: 10.21037/jtd.2019.06.15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
322 Haidry R, Lovat L, Sharma P. Radiofrequency ablation for Barrett's dysplasia: past, present and the future? Curr Gastroenterol Rep 2015;17:13. [PMID: 25740248 DOI: 10.1007/s11894-015-0433-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
323 Yamasaki T, Sakiani S, Maradey-romero C, Mehta R, Sandhu D, Ganocy S, Hemond C, Eisa M, Fass R. Barrett’s esophagus patients are becoming younger: analysis of a large United States dataset. Esophagus 2020;17:190-6. [DOI: 10.1007/s10388-019-00707-7] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
324 Duggan C, Onstad L, Hardikar S, Blount PL, Reid BJ, Vaughan TL. Association between markers of obesity and progression from Barrett’s esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2013;11:934-943. [PMID: 23466711 DOI: 10.1016/j.cgh.2013.02.017] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
325 Huhta H, Melkko J, Kuopio T, Karttunen TJ, Helminen O. Risk of progression in Barrett's esophagus based on diagnoses of general and gastrointestinal pathologists. A retrospective case-control study from Northern and Central Finland. Scand J Gastroenterol 2022;:1-6. [PMID: 35450519 DOI: 10.1080/00365521.2022.2063033] [Reference Citation Analysis]
326 Nelsen EM, Hawes RH, Iyer PG. Diagnosis and management of Barrett’s esophagus. Surg Clin North Am. 2012;92:1135-1154. [PMID: 23026274 DOI: 10.1016/j.suc.2012.07.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
327 Ekheden I, Ludvigsson JF, Yin L, Elbe P, Ye W. Esophageal abnormalities and the risk for gastroesophageal cancers-a histopathology-register-based study in Sweden. Eur J Epidemiol 2022. [PMID: 34978667 DOI: 10.1007/s10654-021-00833-6] [Reference Citation Analysis]
328 Barr H, Almond M. The future developments in upper GI cancer. Frontline Gastroenterol 2012;3:i24-7. [PMID: 28839688 DOI: 10.1136/flgastro-2012-100113] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
329 Marketkar S, Li D, Yang D, Cao W. TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett’s esophagus: Case series and findings. World J Gastroenterol 2017; 23(8): 1338-1344 [PMID: 28293080 DOI: 10.3748/wjg.v23.i8.1338] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
330 Szymański M, Marek I, Wilczyński M, Janczy A, Bigda J, Kaska Ł, Proczko-stepaniak M. Evaluation of esophageal pathology in a group of patients 2 years after one-anastomosis gastric bypass (OAGB) — Cohort study. Obesity Research & Clinical Practice 2021. [DOI: 10.1016/j.orcp.2021.12.001] [Reference Citation Analysis]
331 Brosnan C, Hannan E, Duggan W, Harding T, Maguire D, Stafford AT. Diagnostic Inaccuracies of Barrett's Oesophagus on Gastroscopy: Are We Performing Unnecessary Surveillance? Cureus 2020;12:e9850. [PMID: 32953357 DOI: 10.7759/cureus.9850] [Reference Citation Analysis]
332 Ochuba O, Ruo SW, Alkayyali T, Sandhu JK, Waqar A, Jain A, Joseph C, Srivastava K, Poudel S. Endoscopic Surveillance in Idiopathic Achalasia. Cureus 2021;13:e17436. [PMID: 34513522 DOI: 10.7759/cureus.17436] [Reference Citation Analysis]
333 Killcoyne S, Fitzgerald RC. Evolution and progression of Barrett's oesophagus to oesophageal cancer. Nat Rev Cancer 2021;21:731-41. [PMID: 34545238 DOI: 10.1038/s41568-021-00400-x] [Reference Citation Analysis]
334 Moole H, Patel J, Ahmed Z, Duvvuri A, Vennelaganti S, Moole V, Dharmapuri S, Boddireddy R, Yedama P, Bondalapati N, Uppu A, Vennelaganti P, Puli S. Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists. World J Gastroenterol 2016; 22(39): 8831-8843 [PMID: 27818599 DOI: 10.3748/wjg.v22.i39.8831] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
335 Le Bras GF, Farooq MH, Falk GW, Andl CD. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacol Res 2016;113:236-44. [PMID: 27565381 DOI: 10.1016/j.phrs.2016.08.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
336 Falk GW. Update on ablation for Barrett's esophagus. Curr Gastroenterol Rep 2014;16:368. [PMID: 24357349 DOI: 10.1007/s11894-013-0368-7] [Reference Citation Analysis]
337 Lee SA, Liu F, Yun DY, Riordan SM, Tay ACY, Liu L, Lee CS, Zhang L. Campylobacter concisus upregulates PD-L1 mRNA expression in IFN-γ sensitized intestinal epithelial cells and induces cell death in esophageal epithelial cells. J Oral Microbiol 2021;13:1978732. [PMID: 34552702 DOI: 10.1080/20002297.2021.1978732] [Reference Citation Analysis]
338 Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD, Davison JM, Nason KS, Loda M, Leshchiner I, Stewart C, Stojanov P, Seepo S, Lawrence MS, Ferrer-Torres D, Lin J, Chang AC, Gabriel SB, Lander ES, Beer DG, Getz G, Carter SL, Bass AJ. Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat Genet 2015;47:1047-55. [PMID: 26192918 DOI: 10.1038/ng.3343] [Cited by in Crossref: 209] [Cited by in F6Publishing: 181] [Article Influence: 29.9] [Reference Citation Analysis]
339 Abbas G, Krasna M. Overview of esophageal cancer. Ann Cardiothorac Surg. 2017;6:131-136. [PMID: 28447001 DOI: 10.21037/acs.2017.03.03] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 11.2] [Reference Citation Analysis]
340 Murakami K, Matsubara H. Chronology of gastrointestinal cancer. Surg Today 2018;48:365-70. [PMID: 28795270 DOI: 10.1007/s00595-017-1574-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
341 Fleury E, Nimir C, D'Alessandro GS. The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma? Breast Cancer (Dove Med Press) 2021;13:45-58. [PMID: 33488119 DOI: 10.2147/BCTT.S294166] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
342 Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, Lee Y, Friedman R, Asfaha S, Dubeykovskaya Z, Mahmood U, Figueiredo JL, Kitajewski J, Shawber C, Lightdale CJ, Rustgi AK, Wang TC. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21:36-51. [PMID: 22264787 DOI: 10.1016/j.ccr.2011.12.004] [Cited by in Crossref: 280] [Cited by in F6Publishing: 249] [Article Influence: 28.0] [Reference Citation Analysis]
343 Runge TM, Shaheen NJ, Djukic Z, Hallquist S, Orlando RC. Cleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium. Dig Dis Sci 2016;61:3169-75. [PMID: 27659669 DOI: 10.1007/s10620-016-4315-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
344 de Jonge PJ, van Blankenstein M, Grady WM, Kuipers EJ. Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63:191-202. [PMID: 24092861 DOI: 10.1136/gutjnl-2013-305490] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
345 Muñoz-Largacha JA, Litle VR. Endoscopic mucosal ablation and resection of Barrett's esophagus and related diseases. J Vis Surg 2017;3:128. [PMID: 29078688 DOI: 10.21037/jovs.2017.07.10] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
346 Cohen E, Sawyer JK, Peterson NG, Dow JAT, Fox DT. Physiology, Development, and Disease Modeling in the Drosophila Excretory System. Genetics 2020;214:235-64. [PMID: 32029579 DOI: 10.1534/genetics.119.302289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
347 van Nistelrooij AMJ, van Marion R, van Ijcken WFJ, de Klein A, Wagner A, Biermann K, Spaander MCW, van Lanschot JJB, Dinjens WNM, Wijnhoven BPL. Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma. Fam Cancer 2018;17:435-40. [PMID: 29134539 DOI: 10.1007/s10689-017-0054-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
348 Sharma N, Hui T, Wong HC, Srivastava S, Teh M, Yeoh KG, Ho KY. Risk stratifying the screening of Barrett's esophagus: An Asian perspective. JGH Open 2017;1:68-73. [PMID: 30483537 DOI: 10.1002/jgh3.12013] [Reference Citation Analysis]
349 Gan P, Fan W, Zhang H, Zhong C, Xia H, Lü M, Zhou X, Tang X. The Top-Cited Articles With a Focus on Barrett's Esophagus: A Bibliometric Analysis. Front Surg 2022;9:743274. [DOI: 10.3389/fsurg.2022.743274] [Reference Citation Analysis]
350 Rajendra S, Sharma P. Barrett's Esophagus. Curr Treat Options Gastroenterol 2014;12:169-82. [PMID: 24634008 DOI: 10.1007/s11938-014-0012-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
351 Vance RB Jr, Kubiliun N, Dunbar KB. How Do We Manage Gastric Intestinal Metaplasia? Dig Dis Sci. 2016;61:1870-1878. [PMID: 26984230 DOI: 10.1007/s10620-016-4107-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
352 Okereke I, Hamilton C, Wenholz A, Jala V, Giang T, Reynolds S, Miller A, Pyles R. Associations of the microbiome and esophageal disease. J Thorac Dis 2019;11:S1588-93. [PMID: 31489225 DOI: 10.21037/jtd.2019.05.82] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
353 Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J. Clinical prediction model for tumor progression in Barrett's esophagus. Surg Endosc 2019;33:2901-8. [PMID: 30456503 DOI: 10.1007/s00464-018-6590-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
354 Eberl S, Preckel B, Bergman JJ, Hollmann MW. Safety and effectiveness using dexmedetomidine versus propofol TCI sedation during oesophagus interventions: a randomized trial. BMC Gastroenterol. 2013;13:176. [PMID: 24377675 DOI: 10.1186/1471-230x-13-176] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
355 Shaheen NJ, Kim HP, Bulsiewicz WJ, Lyday WD, Triadafilopoulos G, Wolfsen HC, Komanduri S, Chmielewski GW, Ertan A, Corbett FS, Camara DS, Rothstein RI, Overholt BF. Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry. J Gastrointest Surg 2013;17:21-8; discussion p.28-9. [PMID: 22965650 DOI: 10.1007/s11605-012-2001-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
356 Hartman KG, Bortner JD Jr, Falk GW, Ginsberg GG, Jhala N, Yu J, Martín MG, Rustgi AK, Lynch JP. Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med (Maywood) 2014;239:1108-23. [PMID: 24781339 DOI: 10.1177/1535370214529388] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
357 Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR, Chmielewski GW, Corbett FS, Camara DS, Lightdale CJ, Wolfsen H, Chang KJ, Overholt BF, Pruitt RE, Ertan A, Komanduri S, Infantolino A, Rothstein RI, Shaheen NJ. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology 2015;149:1752-1761.e1. [PMID: 26327132 DOI: 10.1053/j.gastro.2015.08.048] [Cited by in F6Publishing: 39] [Reference Citation Analysis]
358 van Putten M, Johnston BT, Murray LJ, Gavin AT, McManus DT, Bhat S, Turkington RC, Coleman HG. 'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study. United European Gastroenterol J 2018;6:519-28. [PMID: 29881607 DOI: 10.1177/2050640617737466] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
359 Tsai TH, Zhou C, Tao YK, Lee HC, Ahsen OO, Figueiredo M, Kirtane T, Adler DC, Schmitt JM, Huang Q, Fujimoto JG, Mashimo H. Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett's esophagus radiofrequency ablation treatment response (with videos). Gastrointest Endosc. 2012;76:1104-1112. [PMID: 22831857 DOI: 10.1016/j.gie.2012.05.024] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
360 Cooper S, Menon S, Nightingale P, Trudgill Nj. Risk factors for the development of oesophageal adenocarcinoma in Barrett’s oesophagus: a UK primary care retrospective nested case-control study. United European Gastroenterol J. 2014;2:91-98. [PMID: 24918013 DOI: 10.1177/2050640614523596] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
361 Mansour NM, El-Serag HB, Anandasabapathy S. Barrett's esophagus: best practices for treatment and post-treatment surveillance. Ann Cardiothorac Surg 2017;6:75-87. [PMID: 28446996 DOI: 10.21037/acs.2017.03.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
362 Li N, Pasricha S, Bulsiewicz WJ, Pruitt RE, Komanduri S, Wolfsen HC, Chmielewski GW, Corbett FS, Chang KJ, Shaheen NJ. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry. Dis Esophagus. 2016;29:537-543. [PMID: 26121935 DOI: 10.1111/dote.12386] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
363 Hadjinicolaou AV, van Munster SN, Achilleos A, Santiago Garcia J, Killcoyne S, Ragunath K, Bergman JJGHM, Fitzgerald RC, di Pietro M. Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study. EBioMedicine 2020;56:102765. [PMID: 32460165 DOI: 10.1016/j.ebiom.2020.102765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
364 Rasch S, Algül H. A clinical perspective on the role of chronic inflammation in gastrointestinal cancer. Clin Exp Gastroenterol 2014;7:261-72. [PMID: 25143751 DOI: 10.2147/CEG.S43457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
365 Pasricha S, Li N, Bulsiewicz WJ, Rothstein RI, Infantolino A, Ertan A, Camara DS, Dellon ES, Triadafilopoulos G, Lightdale CJ, Madanick RD, Lyday WD, Muthusamy RV, Overholt BF, Shaheen NJ. Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry. Gastrointest Endosc. 2015;82:276-284. [PMID: 25841575 DOI: 10.1016/j.gie.2015.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
366 Visrodia K, Singh S, Krishnamoorthi R, Ahlquist DA, Wang KK, Iyer PG, Katzka DA. Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150:599-607.e7; quiz e14-5. [PMID: 26619962 DOI: 10.1053/j.gastro.2015.11.040] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 10.3] [Reference Citation Analysis]
367 Khalaf N, Ramsey D, Kramer JR, El-Serag HB. Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus 2015;28:283-90. [PMID: 24529029 DOI: 10.1111/dote.12185] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
368 Naveed M, Dunbar KB. Endoscopic imaging of Barrett’s esophagus. World J Gastrointest Endosc 2016; 8(5): 259-266 [PMID: 26981177 DOI: 10.4253/wjge.v8.i5.259] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
369 de Jonge PJ, Spaander MC, Bruno MJ, Kuipers EJ. Acid suppression and surgical therapy for Barrett's oesophagus. Best Pract Res Clin Gastroenterol 2015;29:139-50. [PMID: 25743462 DOI: 10.1016/j.bpg.2014.11.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
370 Lagisetty KH, McEwen DP, Nancarrow DJ, Schiebel JG, Ferrer-Torres D, Ray D, Frankel TL, Lin J, Chang AC, Kresty LA, Beer DG. Immune determinants of Barrett's progression to esophageal adenocarcinoma. JCI Insight 2021;6:143888. [PMID: 33290281 DOI: 10.1172/jci.insight.143888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
371 Borgmann M, Quante M. Impact of the Tumor Microenvironment for Esophageal Tumor Development—An Opportunity for Prevention? Cancers 2022;14:2246. [DOI: 10.3390/cancers14092246] [Reference Citation Analysis]
372 Eluri S, Shaheen NJ. Barrett's esophagus: diagnosis and management. Gastrointest Endosc. 2017;85:889-903. [PMID: 28109913 DOI: 10.1016/j.gie.2017.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
373 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Reference Citation Analysis]
374 Chis R, Hew S, Hopman W, Hookey L, Bechara R. Taking the Next Steps in Endoscopic Visual Assessment of Barrett's Esophagus: A Pilot Study. Clin Exp Gastroenterol 2021;14:113-22. [PMID: 33911891 DOI: 10.2147/CEG.S293477] [Reference Citation Analysis]
375 Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World J Meta-Anal 2019; 7(9): 406-417 [DOI: 10.13105/wjma.v7.i9.406] [Reference Citation Analysis]
376 Segal F, Breyer HP. Diagnosis and management of Barrett’s metaplasia: What’s new. World J Gastrointest Endosc 2012; 4(9): 379-386 [PMID: 23125895 DOI: 10.4253/wjge.v4.i9.379] [Reference Citation Analysis]
377 Karamchandani DM, Zhang Q, Liao XY, Xu JH, Liu XL. Inflammatory bowel disease- and Barrett's esophagus-associated neoplasia: the old, the new, and the persistent struggles. Gastroenterol Rep (Oxf) 2019;7:379-95. [PMID: 31857901 DOI: 10.1093/gastro/goz032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
378 Chedgy FJQ, Subramaniam S, Kandiah K, Thayalasekaran S, Bhandari P. Acetic acid chromoendoscopy: Improving neoplasia detection in Barrett's esophagus. World J Gastroenterol 2016; 22(25): 5753-5760 [PMID: 27433088 DOI: 10.3748/wjg.v22.i25.5753] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
379 van Nistelrooij AM, van der Korput HA, Broer L, van Marion R, van Berge Henegouwen MI, van Noesel CJ, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Hofman A, Uitterlinden AG, Wijnhoven BP, Dinjens WN. Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma. J Carcinog 2015;14:5. [PMID: 26085818 DOI: 10.4103/1477-3163.157441] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
380 Farfus AW, Griffiths EA, Thompson SK, Devitt PG. Current Australian practice in the diagnosis and management of Barrett's oesophagus. ANZ J Surg 2013;83:895-8. [PMID: 24436954 DOI: 10.1111/ans.12372] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
381 Tan WK, Rattan A, O'Donovan M, Nuckcheddy T, Alias B, Sujendran V, di Pietro M. Comparative outcomes of radiofrequency ablation for Barrett's oesophagus with different baseline histology. United European Gastroenterol J 2018;6:662-8. [PMID: 30083327 DOI: 10.1177/2050640617752183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
382 Hao J, Critchley-Thorne R, Diehl DL, Snyder SR. A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus. Clinicoecon Outcomes Res 2019;11:623-35. [PMID: 31749626 DOI: 10.2147/CEOR.S221741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
383 Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. [PMID: 28748917 DOI: 10.1038/nrdp.2017.48] [Cited by in Crossref: 249] [Cited by in F6Publishing: 246] [Article Influence: 49.8] [Reference Citation Analysis]
384 Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, Weiss NS. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013;145:312-319.e1. [PMID: 23673354 DOI: 10.1053/j.gastro.2013.05.004] [Cited by in Crossref: 163] [Cited by in F6Publishing: 145] [Article Influence: 18.1] [Reference Citation Analysis]
385 Ng CK, Ma K, Cheng Y, Miyashita T, Harmon JW, Meltzer SJ. Krüppel-like Factor 5 Promotes Sonic Hedgehog Signaling and Neoplasia in Barrett's Esophagus and Esophageal Adenocarcinoma. Transl Oncol 2019;12:1432-41. [PMID: 31401336 DOI: 10.1016/j.tranon.2019.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
386 Cook MB, Coburn SB, Lam JR, Taylor PR, Schneider JL, Corley DA. Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut. 2018;67:418-529. [PMID: 28053055 DOI: 10.1136/gutjnl-2016-312223] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
387 Kristo I, Schoppmann S, Riegler M, Püspök A, Emmanuel K, Spaun G, Wrba F, Wenzl E, Schöfl R, Schreiber F, Häfner M, Madl C. Austrian expert panel recommendation for radiofrequency ablation of Barrett’s esophagus. Eur Surg 2015;47:319-23. [DOI: 10.1007/s10353-015-0362-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
388 Stapley S, Peters TJ, Neal RD, Rose PW, Walter FM, Hamilton W. The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case-control study using electronic records. Br J Cancer 2013;108:25-31. [PMID: 23257895 DOI: 10.1038/bjc.2012.551] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
389 Martinez P, Timmer MR, Lau CT, Calpe S, Sancho-Serra Mdel C, Straub D, Baker AM, Meijer SL, Kate FJ, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Bergman JJ, Maley CC, Graham TA, Krishnadath KK. Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus. Nat Commun 2016;7:12158. [PMID: 27538785 DOI: 10.1038/ncomms12158] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 9.2] [Reference Citation Analysis]
390 Dilworth MP, Nieto T, Stockton JD, Whalley CM, Tee L, James JD, Noble F, Underwood TJ, Hallissey MT, Hejmadi R, Trudgill N, Tucker O, Beggs AD. Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer. Ann Surg 2019;269:479-85. [PMID: 29384778 DOI: 10.1097/SLA.0000000000002658] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
391 Triggs JR, Falk GW. Best Practices in Surveillance for Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:59-75. [PMID: 33213800 DOI: 10.1016/j.giec.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
392 Abrams JA, Appelman HD, Beer DG, Berry LD, Chak A, Falk GW, Fitzgerald RC, Ginsberg GG, Grady WM, Joshi BP, Lynch JP, Markowitz S, Richmond ES, Rustgi AK, Seibel EJ, Shaheen NJ, Shyr Y, Umar A, Wang KK, Wang TC, Wang TD, Yassin R. Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research. Gastroenterology 2014;146:1586-90. [PMID: 24768332 DOI: 10.1053/j.gastro.2014.04.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
393 Baretton GB, Aust DE. [Barrett's esophagus. An update]. Pathologe. 2012;33:5-16. [PMID: 22293785 DOI: 10.1007/s00292-011-1541-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
394 Petrov RV, Fajardo RA, Bakhos CT, Abbas AE. Peroral endoscopic myotomy: techniques and outcomes. Shanghai Chest 2021;5:14. [PMID: 34013165 DOI: 10.21037/shc.2020.02.02] [Reference Citation Analysis]
395 Azarm A, Lukolic I, Shukla M, Concha-Parra R, Gress F. Endoscopic management of Barrett's esophagus: advances in endoscopic techniques. Dig Dis Sci 2012;57:3055-64. [PMID: 22760590 DOI: 10.1007/s10620-012-2279-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
396 Cotton CC, Duits LC, Wolf WA, Peery AF, Dellon ES, Bergman JJ, Shaheen NJ. Spatial predisposition of dysplasia in Barrett's esophagus segments: a pooled analysis of the SURF and AIM dysplasia trials. Am J Gastroenterol 2015;110:1412-9. [PMID: 26346864 DOI: 10.1038/ajg.2015.263] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
397 Thrift AP, Kendall BJ, Pandeya N, Vaughan TL, Whiteman DC; Study of Digestive Health. A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) 2012;5:1115-23. [PMID: 22787114 DOI: 10.1158/1940-6207.CAPR-12-0010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
398 Golger D, Probst A, Messmann H. Barrett's esophagus: lessons from recent clinical trials. Ann Gastroenterol 2016;29:417-23. [PMID: 27708506 DOI: 10.20524/aog.2016.0070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
399 Findlay JM, Middleton MR, Tomlinson I. Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis. Dig Dis Sci 2016;61:25-38. [PMID: 26445852 DOI: 10.1007/s10620-015-3884-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
400 Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L. Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma. Clin Exp Gastroenterol 2019;12:219-29. [PMID: 31190949 DOI: 10.2147/CEG.S186958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
401 Newell F, Patel K, Gartside M, Krause L, Brosda S, Aoude LG, Loffler KA, Bonazzi VF, Patch AM, Kazakoff SH, Holmes O, Xu Q, Wood S, Leonard C, Lampe G, Lord RV, Whiteman DC, Pearson JV, Nones K, Waddell N, Barbour AP. Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples. BMC Med Genomics 2019;12:31. [PMID: 30717762 DOI: 10.1186/s12920-019-0476-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
402 Patel A, Gyawali CP. Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness. J Neurogastroenterol Motil 2019;25:181-8. [PMID: 30827080 DOI: 10.5056/jnm18156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
403 Sturm MB, Wang TD. Emerging optical methods for surveillance of Barrett’s oesophagus. Gut. 2015;64:1816-1823. [PMID: 25975605 DOI: 10.1136/gutjnl-2013-306706] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 7.1] [Reference Citation Analysis]
404 Bennett M, Mashimo H. Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus. World J Gastrointest Pathophysiol 2014; 5(4): 438-449 [PMID: 25400987 DOI: 10.4291/wjgp.v5.i4.438] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
405 Quante M, Wang TC, Bass AJ. Adenocarcinoma of the oesophagus: is it gastric cancer? Gut 2022:gutjnl-2022-327096. [PMID: 35365571 DOI: 10.1136/gutjnl-2022-327096] [Reference Citation Analysis]
406 Han S, Wani S. Quality Indicators in Endoscopic Ablation for Barrett's Esophagus. Curr Treat Options Gastroenterol 2017;15:241-55. [PMID: 28421454 DOI: 10.1007/s11938-017-0136-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
407 Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology 2018;154:2068-2086.e5. [PMID: 29458154 DOI: 10.1053/j.gastro.2018.02.022] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 15.3] [Reference Citation Analysis]
408 Brown CS, Ujiki MB. Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence. World J Gastrointest Endosc 2015; 7(5): 438-445 [PMID: 25992184 DOI: 10.4253/wjge.v7.i5.438] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
409 Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology. 2015;149:567-76.e3; quiz e13-4. [PMID: 25917785 DOI: 10.1053/j.gastro.2015.04.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
410 Triadafilopoulos G. Revis(it)ing Barrett's esophagus. Gastrointest Endosc 2014;79:574-6. [PMID: 24630083 DOI: 10.1016/j.gie.2013.11.007] [Reference Citation Analysis]
411 Wood NJ. Barrett esophagus: Need for ongoing surveillance called into question for patients with non-dysplastic Barrett esophagus. Nat Rev Gastroenterol Hepatol. 2011;8:657. [PMID: 22138905 DOI: 10.1038/nrgastro.2011.204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
412 Panda A, Bhanot G, Ganesan S, Bajpai M. Gene Expression in Barrett's Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma. Cancers (Basel) 2021;13:5971. [PMID: 34885081 DOI: 10.3390/cancers13235971] [Reference Citation Analysis]
413 Carlson DA, Hinchcliff M, Pandolfino JE. Advances in the evaluation and management of esophageal disease of systemic sclerosis. Curr Rheumatol Rep. 2015;17:475. [PMID: 25475597 DOI: 10.1007/s11926-014-0475-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
414 Saller J, Jiang K, Xiong Y, Yoder SJ, Neill K, Pimiento JM, Pena L, Corbett FS, Magliocco A, Coppola D. A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer. Dig Dis Sci 2021. [PMID: 33713247 DOI: 10.1007/s10620-021-06863-0] [Reference Citation Analysis]
415 Chan DKH, Buczacki SJA. Tumour heterogeneity and evolutionary dynamics in colorectal cancer. Oncogenesis 2021;10:53. [PMID: 34272358 DOI: 10.1038/s41389-021-00342-x] [Reference Citation Analysis]
416 Garman KS, Ajayi TA, Boutte HJ Jr, Chiu ST, von Furstenberg RJ, Lloyd BR, Zhang C, Onaitis MW, Chow SC, McCall SJ. Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma. PLoS One 2020;15:e0235906. [PMID: 32697782 DOI: 10.1371/journal.pone.0235906] [Reference Citation Analysis]
417 Schellnegger R, Quante A, Rospleszcz S, Schernhammer M, Höhl B, Tobiasch M, Pastula A, Brandtner A, Abrams JA, Strauch K, Schmid RM, Vieth M, Wang TC, Quante M. Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma. Cancer Prev Res (Phila) 2017;10:55-66. [PMID: 27807078 DOI: 10.1158/1940-6207.CAPR-16-0117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
418 Liu N, Ando T, Ishiguro K, Maeda O, Watanabe O, Funasaka K, Nakamura M, Miyahara R, Ohmiya N, Goto H. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus. BMC Infect Dis. 2013;13:130. [PMID: 23496929 DOI: 10.1186/1471-2334-13-130] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
419 Ten Kate FJC, van Olphen SH, Bruno MJ, Wijnhoven BPL, van Lanschot JJB, Looijenga LHJ, Fitzgerald RC, Biermann K. Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma. Br J Surg 2017;104:1327-37. [PMID: 28692180 DOI: 10.1002/bjs.10553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
420 Lim CH, Lee PC, Lim E, Tan J, Chan WH, Tan HC, Ganguly S, Tham KW, Eng A. Correlation Between Symptomatic Gastro-Esophageal Reflux Disease (GERD) and Erosive Esophagitis (EE) Post-vertical Sleeve Gastrectomy (VSG). Obes Surg 2019;29:207-14. [PMID: 30238218 DOI: 10.1007/s11695-018-3509-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
421 Barrie J, Yanni F, Sherif M, Dube AK, Tamhankar AP. Length of Barrett's esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Surg Endosc 2021;35:4756-62. [PMID: 32880012 DOI: 10.1007/s00464-020-07950-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
422 Visrodia K, Iyer PG, Schleck CD, Zinsmeister AR, Katzka DA. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study. Dig Dis Sci 2016;61:158-67. [PMID: 25956705 DOI: 10.1007/s10620-015-3697-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
423 Realdon S, Antonello A, Arcidiacono D, Dassie E, Cavallin F, Fassan M, Nardi MT, Alberti A, Rugge M, Battaglia G. Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population. Eur J Nutr 2016;55:1563-71. [PMID: 26155779 DOI: 10.1007/s00394-015-0975-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
424 Hui YY, Chen X, Wang BM. Yesterday and today of Barrett's esophagus: Historical evolution and research hotspots. Shijie Huaren Xiaohua Zazhi 2016; 24(20): 3077-3086 [DOI: 10.11569/wcjd.v24.i20.3077] [Reference Citation Analysis]
425 Saligram S, Tofteland N, Wani S, Gupta N, Mathur S, Vennalaganti P, Kanakadandi V, Giacchino M, Higbee A, Lim D, Rastogi A, Bansal A, Sharma P. Long-term results of the mucosal ablation of Barrett's esophagus: efficacy and recurrence. Endosc Int Open 2015;3:E189-94. [PMID: 26171429 DOI: 10.1055/s-0034-1391669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
426 Liu Y. Artificial intelligence-assisted endoscopic detection of esophageal neoplasia in early stage: The next step? World J Gastroenterol 2021; 27(14): 1392-1405 [PMID: 33911463 DOI: 10.3748/wjg.v27.i14.1392] [Reference Citation Analysis]
427 Hong J, Li D, Wands J, Souza R, Cao W. Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells. Am J Physiol Cell Physiol 2013;305:C1069-79. [PMID: 24025864 DOI: 10.1152/ajpcell.00080.2013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
428 Fassan M, Dall'Olmo L, Galasso M, Braconi C, Pizzi M, Realdon S, Volinia S, Valeri N, Gasparini P, Baffa R, Souza RF, Vicentini C, D'Angelo E, Bornschein J, Nuovo GJ, Zaninotto G, Croce CM, Rugge M. Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. Oncotarget 2014;5:7162-71. [PMID: 25216530 DOI: 10.18632/oncotarget.2249] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
429 Alkaddour A, Palacio C, Vega KJ. Risk of histologic Barrett's esophagus between African Americans and non-Hispanic whites: A meta-analysis. United European Gastroenterol J 2018;6:22-8. [PMID: 29435310 DOI: 10.1177/2050640617707862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
430 Milashka M, Calomme A, Van Laethem JL, Blero D, Eisendrath P, Le Moine O, Devière J. Sixteen-year follow-up of Barrett's esophagus, endoscopically treated with argon plasma coagulation. United European Gastroenterol J 2014;2:367-73. [PMID: 25360314 DOI: 10.1177/2050640614549095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
431 Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer 2018;18:19-32. [PMID: 29217838 DOI: 10.1038/nrc.2017.102] [Cited by in Crossref: 157] [Cited by in F6Publishing: 157] [Article Influence: 31.4] [Reference Citation Analysis]
432 Yan T, Wong PK, Qin YY. Deep learning for diagnosis of precancerous lesions in upper gastrointestinal endoscopy: A review. World J Gastroenterol 2021; 27(20): 2531-2544 [PMID: 34092974 DOI: 10.3748/wjg.v27.i20.2531] [Reference Citation Analysis]
433 Fajardo RA, Petrov RV, Bakhos CT, Abbas AE. Endoscopic and Surgical Treatments for Achalasia: Who to Treat and How? Gastroenterol Clin North Am 2020;49:481-98. [PMID: 32718566 DOI: 10.1016/j.gtc.2020.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
434 Timmer MR, Martinez P, Lau CT, Westra WM, Calpe S, Rygiel AM, Rosmolen WD, Meijer SL, Ten Kate FJ, Dijkgraaf MG, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Maley CC, Graham TA, Bergman JJ, Krishnadath KK. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study. Gut 2016;65:1602-10. [PMID: 26104750 DOI: 10.1136/gutjnl-2015-309642] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
435 Singh A, Chak A. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Rep (Oxf). 2015;3:303-315. [PMID: 26486568 DOI: 10.1093/gastro/gov048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
436 Crous-Bou M, Jovani M, De Vivo I, Jacobson BC. Gene-Environment Interactions and the Risk of Barrett's Esophagus in Three US Cohorts. Am J Gastroenterol 2019;114:893-9. [PMID: 30950840 DOI: 10.14309/ajg.0000000000000219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
437 Sundriyal D, Shirsi N, Kotwal S, Kumar S, Mithran Parthasarthy K, Gupta M. Adenocarcinoma of Cervical Esophagus Arising in the Barrett's Mucosa. Indian J Surg Oncol 2015;6:127-9. [PMID: 26405420 DOI: 10.1007/s13193-015-0382-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
438 Zhao Z, Yin Z, Zhang C. Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants. Cancer Med 2021;10:5297-320. [PMID: 34128354 DOI: 10.1002/cam4.4061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
439 Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2015;44:203-231. [PMID: 26021191 DOI: 10.1016/j.gtc.2015.02.001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 82] [Article Influence: 14.9] [Reference Citation Analysis]
440 Ebigbo A, Messmann H, Römmele C. Endoscopic Upper GI Screening. Visc Med 2019;35:240-4. [PMID: 31602385 DOI: 10.1159/000501889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
441 Choi WT, Lauwers GY, Montgomery EA. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Mod Pathol 2022. [PMID: 35260826 DOI: 10.1038/s41379-022-01056-0] [Reference Citation Analysis]
442 Ness-Jensen E. Epidemiology and prevention of oesophageal adenocarcinoma. Scand J Gastroenterol 2022;:1-5. [PMID: 35234549 DOI: 10.1080/00365521.2022.2042594] [Reference Citation Analysis]
443 Eluri S, Brugge WR, Daglilar ES, Jackson SA, Styn MA, Callenberg KM, Welch DC, Barr TM, Duits LC, Bergman JJ. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Am J Gastroenterol. 2015;110:828-834. [PMID: 26010308 DOI: 10.1038/ajg.2015.152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
444 Sędzikowska A, Szablewski L. Human Gut Microbiota in Health and Selected Cancers. Int J Mol Sci 2021;22:13440. [PMID: 34948234 DOI: 10.3390/ijms222413440] [Reference Citation Analysis]
445 Yang M, Liu R, Li X, Liao J, Pu Y, Pan E, Yin L, Wang Y. miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. Mol Cells 2014;37:873-80. [PMID: 25518924 DOI: 10.14348/molcells.2014.0147] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
446 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
447 Sauk J, Coron E, Kava L, Suter M, Gora M, Gallagher K, Rosenberg M, Ananthakrishnan A, Nishioka N, Lauwers G. Interobserver agreement for the detection of Barrett’s esophagus with optical frequency domain imaging. Dig Dis Sci. 2013;58:2261-2265. [PMID: 23508980 DOI: 10.1007/s10620-013-2625-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
448 Fisher OM, Levert-Mignon AJ, Lord SJ, Lee-Ng KK, Botelho NK, Falkenback D, Thomas ML, Bobryshev YV, Whiteman DC, Brown DA, Breit SN, Lord RV. MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma. Br J Cancer 2015;112:1384-91. [PMID: 25867265 DOI: 10.1038/bjc.2015.100] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
449 Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600 [PMID: 28082811 DOI: 10.3748/wjg.v22.i48.10592] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
450 Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol 2019;17:864-8. [PMID: 30012433 DOI: 10.1016/j.cgh.2018.07.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
451 Kuipers EJ, Spaander MC. Natural History of Barrett's Esophagus. Dig Dis Sci 2018;63:1997-2004. [PMID: 29905908 DOI: 10.1007/s10620-018-5161-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
452 Lee Y, Urbanska AM, Hayakawa Y, Wang H, Au AS, Luna AM, Chang W, Jin G, Bhagat G, Abrams JA, Friedman RA, Varro A, Wang KK, Boyce M, Rustgi AK, Sepulveda AR, Quante M, Wang TC. Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus. Oncotarget 2017;8:203-14. [PMID: 27448962 DOI: 10.18632/oncotarget.10667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
453 Chan MW, Pouw RE. Risk-stratification models for Barrett’s esophagus: Will we get to the perfect classifier? Gastrointestinal Endoscopy 2022. [DOI: 10.1016/j.gie.2022.02.028] [Reference Citation Analysis]
454 Gross SA, Smith MS, Kaul V; US Collaborative WATS3D Study Group. Increased detection of Barrett's esophagus and esophageal dysplasia with adjunctive use of wide-area transepithelial sample with three-dimensional computer-assisted analysis (WATS). United European Gastroenterol J 2018;6:529-35. [PMID: 29881608 DOI: 10.1177/2050640617746298] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
455 Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, de Koning HJ, Meester R, Inadomi JM, van Ballegooijen M. An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling. Gastroenterology 2015;149:577-85.e4; quiz e14-5. [PMID: 25935635 DOI: 10.1053/j.gastro.2015.04.045] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]